JP7476498B2 - Method for producing 4-hydroxybenzoic acid or its derivatives and method for producing chemical products - Google Patents
Method for producing 4-hydroxybenzoic acid or its derivatives and method for producing chemical products Download PDFInfo
- Publication number
- JP7476498B2 JP7476498B2 JP2019159035A JP2019159035A JP7476498B2 JP 7476498 B2 JP7476498 B2 JP 7476498B2 JP 2019159035 A JP2019159035 A JP 2019159035A JP 2019159035 A JP2019159035 A JP 2019159035A JP 7476498 B2 JP7476498 B2 JP 7476498B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- producing
- derivative
- hydroxybenzoic acid
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 title claims description 73
- 238000004519 manufacturing process Methods 0.000 title claims description 38
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 title claims description 35
- 239000000126 substance Substances 0.000 title claims description 23
- 239000007788 liquid Substances 0.000 claims description 74
- 239000002994 raw material Substances 0.000 claims description 45
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 36
- 239000007787 solid Substances 0.000 claims description 29
- 238000002425 crystallisation Methods 0.000 claims description 24
- 230000008025 crystallization Effects 0.000 claims description 24
- 238000000926 separation method Methods 0.000 claims description 13
- 239000002028 Biomass Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 238000012546 transfer Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000013078 crystal Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 3
- 238000010998 test method Methods 0.000 claims description 3
- 150000001923 cyclic compounds Chemical class 0.000 description 60
- 229920006395 saturated elastomer Polymers 0.000 description 25
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 125000004432 carbon atom Chemical group C* 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 14
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 12
- -1 isoindolenine Chemical compound 0.000 description 10
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 9
- 125000003118 aryl group Chemical group 0.000 description 8
- 150000001721 carbon Chemical group 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 150000001555 benzenes Chemical class 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 4
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 4
- LBKFGYZQBSGRHY-UHFFFAOYSA-N 3-hydroxy-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1O LBKFGYZQBSGRHY-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 150000001491 aromatic compounds Chemical class 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- YOPYGGKAYWMQAB-UHFFFAOYSA-N diptoindonesin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc(C=Cc3ccc(O)cc3)c4C(C(Oc24)c5ccc(O)cc5)c6cc(O)cc(O)c6 YOPYGGKAYWMQAB-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 3
- IJFXRHURBJZNAO-UHFFFAOYSA-N 3-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 description 3
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- WTFXTQVDAKGDEY-HTQZYQBOSA-N Chorismic acid Natural products O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 3
- RTIXKCRFFJGDFG-UHFFFAOYSA-N Chrysin Natural products C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- DZAUWHJDUNRCTF-UHFFFAOYSA-N dihydrocaffeic acid Natural products OC(=O)CCC1=CC=C(O)C(O)=C1 DZAUWHJDUNRCTF-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- IWYDHOAUDWTVEP-UHFFFAOYSA-N mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- FPWMCUPFBRFMLH-UHFFFAOYSA-N prephenic acid Natural products OC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-UHFFFAOYSA-N 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 3
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FQWLMRXWKZGLFI-YVYUXZJTSA-N (-)-trans-epsilon-viniferin Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC2=C1[C@@H](C=1C=C(O)C=C(O)C=1)[C@H](C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-YVYUXZJTSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- BHLYRWXGMIUIHG-HNNXBMFYSA-N (S)-reticuline Chemical compound C1=C(O)C(OC)=CC=C1C[C@H]1C2=CC(O)=C(OC)C=C2CCN1C BHLYRWXGMIUIHG-HNNXBMFYSA-N 0.000 description 2
- GDVRUDXLQBVIKP-HQHREHCSSA-N 1-O-galloyl-beta-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-HQHREHCSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- KVZUCOGWKYOPID-UHFFFAOYSA-N 2,4,5-Trimethoxybenzoic acid Chemical compound COC1=CC(OC)=C(C(O)=O)C=C1OC KVZUCOGWKYOPID-UHFFFAOYSA-N 0.000 description 2
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 description 2
- FBTSUTGMWBDAAC-UHFFFAOYSA-N 3,4-Dihydroxystyrene Chemical compound OC1=CC=C(C=C)C=C1O FBTSUTGMWBDAAC-UHFFFAOYSA-N 0.000 description 2
- LXCUAFVVTHZALS-UHFFFAOYSA-N 3-(3-methoxyphenyl)piperidine Chemical compound COC1=CC=CC(C2CNCCC2)=C1 LXCUAFVVTHZALS-UHFFFAOYSA-N 0.000 description 2
- WVMWZWGZRAXUBK-SYTVJDICSA-M 3-dehydroquinate Chemical compound O[C@@H]1C[C@](O)(C([O-])=O)CC(=O)[C@H]1O WVMWZWGZRAXUBK-SYTVJDICSA-M 0.000 description 2
- WVMWZWGZRAXUBK-UHFFFAOYSA-N 3-dehydroquinic acid Natural products OC1CC(O)(C(O)=O)CC(=O)C1O WVMWZWGZRAXUBK-UHFFFAOYSA-N 0.000 description 2
- SLWWJZMPHJJOPH-PHDIDXHHSA-N 3-dehydroshikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=CC(=O)[C@H]1O SLWWJZMPHJJOPH-PHDIDXHHSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- VXIXUWQIVKSKSA-UHFFFAOYSA-N 4-hydroxycoumarin Chemical compound C1=CC=CC2=C1OC(=O)C=C2O VXIXUWQIVKSKSA-UHFFFAOYSA-N 0.000 description 2
- FUGYGGDSWSUORM-UHFFFAOYSA-N 4-hydroxystyrene Chemical compound OC1=CC=C(C=C)C=C1 FUGYGGDSWSUORM-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- BAVONGHXFVOKBV-UHFFFAOYSA-N Carveol Chemical compound CC(=C)C1CC=C(C)C(O)C1 BAVONGHXFVOKBV-UHFFFAOYSA-N 0.000 description 2
- SLWWJZMPHJJOPH-UHFFFAOYSA-N DHS Natural products OC1CC(C(O)=O)=CC(=O)C1O SLWWJZMPHJJOPH-UHFFFAOYSA-N 0.000 description 2
- XNEFHYFPRJBTJF-UHFFFAOYSA-N Dehydroshikimic acid Chemical compound OC1C=C(C(O)=O)CC(=O)C1O XNEFHYFPRJBTJF-UHFFFAOYSA-N 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- PHIHHTIYURVLDB-UHFFFAOYSA-N H-gnetine Natural products C1=CC(O)=CC=C1C=CC1=C(C(C(O2)C=3C=CC(O)=CC=3)C=3C=C(O)C=C(O)C=3)C2=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 PHIHHTIYURVLDB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000001334 alicyclic compounds Chemical class 0.000 description 2
- 150000007824 aliphatic compounds Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- UJMDYLWCYJJYMO-UHFFFAOYSA-N benzene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1C(O)=O UJMDYLWCYJJYMO-UHFFFAOYSA-N 0.000 description 2
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- JMFRWRFFLBVWSI-NSCUHMNNSA-N coniferol Chemical compound COC1=CC(\C=C\CO)=CC=C1O JMFRWRFFLBVWSI-NSCUHMNNSA-N 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- BOLQJTPHPSDZHR-UHFFFAOYSA-N dihydroferulic acid Chemical compound COC1=CC(CCC(O)=O)=CC=C1O BOLQJTPHPSDZHR-UHFFFAOYSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- ZHQLTKAVLJKSKR-UHFFFAOYSA-N homophthalic acid Chemical compound OC(=O)CC1=CC=CC=C1C(O)=O ZHQLTKAVLJKSKR-UHFFFAOYSA-N 0.000 description 2
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 2
- WUAXWQRULBZETB-UHFFFAOYSA-N homoveratric acid Chemical compound COC1=CC=C(CC(O)=O)C=C1OC WUAXWQRULBZETB-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- YDSWCNNOKPMOTP-UHFFFAOYSA-N mellitic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O YDSWCNNOKPMOTP-UHFFFAOYSA-N 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- NDTYTMIUWGWIMO-UHFFFAOYSA-N perillyl alcohol Chemical compound CC(=C)C1CCC(CO)=CC1 NDTYTMIUWGWIMO-UHFFFAOYSA-N 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- FPWMCUPFBRFMLH-HDKIZWTHSA-N prephenic acid Chemical compound O[C@H]1C=C[C@](CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-HDKIZWTHSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- CYIDZMCFTVVTJO-UHFFFAOYSA-N pyromellitic acid Chemical compound OC(=O)C1=CC(C(O)=O)=C(C(O)=O)C=C1C(O)=O CYIDZMCFTVVTJO-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 150000003436 stilbenoids Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- YCVPRTHEGLPYPB-VOTSOKGWSA-N trans-pinosylvin Chemical compound OC1=CC(O)=CC(\C=C\C=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-VOTSOKGWSA-N 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 2
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 2
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- KUTVNHOAKHJJFL-ZSIJVUTGSA-N (+)-alpha-viniferin Chemical compound C1=CC(O)=CC=C1[C@@H](O1)[C@H]2C(C=C(O)C=C3O[C@H]4C=5C=CC(O)=CC=5)=C3[C@H]4C(C=C(O)C=C3O[C@H]4C=5C=CC(O)=CC=5)=C3[C@H]4C3=C2C1=CC(O)=C3 KUTVNHOAKHJJFL-ZSIJVUTGSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MHXCIKYXNYCMHY-AUSJPIAWSA-N (+)-lariciresinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H]2[C@@H]([C@H](OC2)C=2C=C(OC)C(O)=CC=2)CO)=C1 MHXCIKYXNYCMHY-AUSJPIAWSA-N 0.000 description 1
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 description 1
- RUPUUZZJJXCDHS-UHFFFAOYSA-N (+)-orientaline Natural products C1=C(O)C(OC)=CC(CC2C3=CC(O)=C(OC)C=C3CCN2C)=C1 RUPUUZZJJXCDHS-UHFFFAOYSA-N 0.000 description 1
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- QEBNYNLSCGVZOH-NFAWXSAZSA-N (+)-valencene Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CCC=C21 QEBNYNLSCGVZOH-NFAWXSAZSA-N 0.000 description 1
- NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 description 1
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- MATGKVZWFZHCLI-LSDHHAIUSA-N (-)-matairesinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H]2[C@H](C(=O)OC2)CC=2C=C(OC)C(O)=CC=2)=C1 MATGKVZWFZHCLI-LSDHHAIUSA-N 0.000 description 1
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 1
- PUETUDUXMCLALY-HOTGVXAUSA-N (-)-secoisolariciresinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 PUETUDUXMCLALY-HOTGVXAUSA-N 0.000 description 1
- BAVONGHXFVOKBV-ZJUUUORDSA-N (-)-trans-carveol Natural products CC(=C)[C@@H]1CC=C(C)[C@@H](O)C1 BAVONGHXFVOKBV-ZJUUUORDSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 1
- 239000001890 (2R)-8,8,8a-trimethyl-2-prop-1-en-2-yl-1,2,3,4,6,7-hexahydronaphthalene Substances 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- NWCHELUCVWSRRS-SECBINFHSA-N (2r)-2-hydroxy-2-phenylpropanoic acid Chemical compound OC(=O)[C@@](O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-SECBINFHSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- JEQRSDJVWOFRBQ-ILLDPMRGSA-N (2s,3r)-3-hydroxy-2-[[(2s,3s)-3-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-3,4-dihydrochromene-6-carbonyl]amino]butanoic acid Chemical compound O1[C@@](C)(CCC=C(C)C)[C@@H](O)CC2=CC(C(=O)N[C@@H]([C@H](O)C)C(O)=O)=CC=C21 JEQRSDJVWOFRBQ-ILLDPMRGSA-N 0.000 description 1
- 229940098795 (3z)- 3-hexenyl acetate Drugs 0.000 description 1
- QBLFZIBJXUQVRF-UHFFFAOYSA-N (4-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Br)C=C1 QBLFZIBJXUQVRF-UHFFFAOYSA-N 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- KUWZXOMQXYWKBS-UHFFFAOYSA-N (E)-2-(5-hydroxy-3-methoxyphenyl)-1-(4'-hydroxyphenyl)ethylene Natural products COC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 KUWZXOMQXYWKBS-UHFFFAOYSA-N 0.000 description 1
- PERPNFLGJXUDDW-UHFFFAOYSA-N (E)-3'-beta-D-Glucopyranosyloxy-3,4,5'-trihydroxystilbene Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 PERPNFLGJXUDDW-UHFFFAOYSA-N 0.000 description 1
- ZCKDCRKBURQZPT-OWOJBTEDSA-N (E)-caffeyl alcohol Chemical compound OC\C=C\C1=CC=C(O)C(O)=C1 ZCKDCRKBURQZPT-OWOJBTEDSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- HSTZMXCBWJGKHG-UHFFFAOYSA-N (E)-piceid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-UHFFFAOYSA-N 0.000 description 1
- RUMOYJJNUMEFDD-SNVBAGLBSA-N (R)-(+)-Perillaldehyde Natural products CC(=C)[C@H]1CCC(C=O)=CC1 RUMOYJJNUMEFDD-SNVBAGLBSA-N 0.000 description 1
- FTVWIRXFELQLPI-CYBMUJFWSA-N (R)-naringenin Chemical compound C1=CC(O)=CC=C1[C@@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-CYBMUJFWSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- OYWRDHBGMCXGFY-UHFFFAOYSA-N 1,2,3-triazinane Chemical group C1CNNNC1 OYWRDHBGMCXGFY-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- VBSTXRUAXCTZBQ-UHFFFAOYSA-N 1-hexyl-4-phenylpiperazine Chemical compound C1CN(CCCCCC)CCN1C1=CC=CC=C1 VBSTXRUAXCTZBQ-UHFFFAOYSA-N 0.000 description 1
- BRRSNXCXLSVPFC-UHFFFAOYSA-N 2,3,4-Trihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1O BRRSNXCXLSVPFC-UHFFFAOYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical group C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 description 1
- HGEFWFBFQKWVMY-DUXPYHPUSA-N 2,4-dihydroxy-trans cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1O HGEFWFBFQKWVMY-DUXPYHPUSA-N 0.000 description 1
- VVEMXQMSJUUTFO-UHFFFAOYSA-N 2,6-dihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1O.OC(=O)C1=C(O)C=CC=C1O VVEMXQMSJUUTFO-UHFFFAOYSA-N 0.000 description 1
- TZPBMNKOLMSJPF-BZNQNGANSA-N 2-(beta-D-glucopyranosyloxy)benzoic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1C(O)=O TZPBMNKOLMSJPF-BZNQNGANSA-N 0.000 description 1
- QYCBZFRDGXIZIP-UHFFFAOYSA-N 2-hydroxy-2-phenylbutanoic acid Chemical compound CCC(O)(C(O)=O)C1=CC=CC=C1 QYCBZFRDGXIZIP-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- YOMSJEATGXXYPX-UHFFFAOYSA-N 2-methoxy-4-vinylphenol Chemical compound COC1=CC(C=C)=CC=C1O YOMSJEATGXXYPX-UHFFFAOYSA-N 0.000 description 1
- LFLOMAIEONDOLV-UHFFFAOYSA-N 2-oxalobenzoic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1C(O)=O LFLOMAIEONDOLV-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- ONPJWQSDZCGSQM-UHFFFAOYSA-N 2-phenylprop-2-enoic acid Chemical compound OC(=O)C(=C)C1=CC=CC=C1 ONPJWQSDZCGSQM-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical group N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 description 1
- UMGCIIXWEFTPOC-UHFFFAOYSA-N 3,4,3',5'-Tetrahydroxystilbene-3-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(C=CC=2C=C(O)C=C(O)C=2)=CC=C1O UMGCIIXWEFTPOC-UHFFFAOYSA-N 0.000 description 1
- DAUAQNGYDSHRET-UHFFFAOYSA-N 3,4-dimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1OC DAUAQNGYDSHRET-UHFFFAOYSA-N 0.000 description 1
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- JVGVDSSUAVXRDY-UHFFFAOYSA-N 3-(4-hydroxyphenyl)lactic acid Chemical compound OC(=O)C(O)CC1=CC=C(O)C=C1 JVGVDSSUAVXRDY-UHFFFAOYSA-N 0.000 description 1
- QNUWEXSGZVBMDV-UHFFFAOYSA-N 3-(carboxymethyl)benzoic acid Chemical compound OC(=O)CC1=CC=CC(C(O)=O)=C1 QNUWEXSGZVBMDV-UHFFFAOYSA-N 0.000 description 1
- KUWZXOMQXYWKBS-NSCUHMNNSA-N 3-methoxy-4',5-dihydroxy-trans-stilbene Chemical compound COC1=CC(O)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 KUWZXOMQXYWKBS-NSCUHMNNSA-N 0.000 description 1
- WVPYGTHKWYSUNM-UHFFFAOYSA-N 3-oxalobenzoic acid Chemical compound OC(=O)C(=O)C1=CC=CC(C(O)=O)=C1 WVPYGTHKWYSUNM-UHFFFAOYSA-N 0.000 description 1
- PYIZAVSVITVBMS-UHFFFAOYSA-N 3-phenyl-3,4-dihydrochromene-2,2-diol Chemical class OC1(O)OC2=CC=CC=C2CC1C1=CC=CC=C1 PYIZAVSVITVBMS-UHFFFAOYSA-N 0.000 description 1
- VOXXWSYKYCBWHO-UHFFFAOYSA-M 3-phenyllactate Chemical compound [O-]C(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-M 0.000 description 1
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 1
- ALYNCZNDIQEVRV-PZFLKRBQSA-N 4-amino-3,5-ditritiobenzoic acid Chemical compound [3H]c1cc(cc([3H])c1N)C(O)=O ALYNCZNDIQEVRV-PZFLKRBQSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- IHVRWFJGOIWMGC-NSCUHMNNSA-N 4-methoxyresveratrol Chemical compound C1=CC(OC)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 IHVRWFJGOIWMGC-NSCUHMNNSA-N 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
- SGNZYJXNUURYCH-UHFFFAOYSA-N 5,6-dihydroxyindole Chemical group C1=C(O)C(O)=CC2=C1NC=C2 SGNZYJXNUURYCH-UHFFFAOYSA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- PHIHHTIYURVLDB-JPZOQBBBSA-N 5-[(2s,3s,5s,6s)-3-(3,5-dihydroxyphenyl)-2,6-bis(4-hydroxyphenyl)-4-[(e)-2-(4-hydroxyphenyl)ethenyl]-2,3,5,6-tetrahydrofuro[3,2-f][1]benzofuran-5-yl]benzene-1,3-diol Chemical compound C1=CC(O)=CC=C1\C=C\C1=C([C@@H]([C@H](O2)C=3C=CC(O)=CC=3)C=3C=C(O)C=C(O)C=3)C2=CC2=C1[C@H](C=1C=C(O)C=C(O)C=1)[C@@H](C=1C=CC(O)=CC=1)O2 PHIHHTIYURVLDB-JPZOQBBBSA-N 0.000 description 1
- KMRMUZKLFIEVAO-UHFFFAOYSA-N 7,7-dimethylbicyclo[3.1.1]hept-3-ene-4-carbaldehyde Chemical compound C1C2C(C)(C)C1CC=C2C=O KMRMUZKLFIEVAO-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- PHIHHTIYURVLDB-SIXZTWGTSA-N Ampelopsin E Natural products C1=CC(O)=CC=C1\C=C\C1=C([C@H]([C@H](O2)C=3C=CC(O)=CC=3)C=3C=C(O)C=C(O)C=3)C2=CC2=C1[C@@H](C=1C=C(O)C=C(O)C=1)[C@H](C=1C=CC(O)=CC=1)O2 PHIHHTIYURVLDB-SIXZTWGTSA-N 0.000 description 1
- YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- MIEILDYWGANZNH-UHFFFAOYSA-N Arogenic acid Natural products OC(=O)C(N)CC1(C(O)=O)C=CC(O)C=C1 MIEILDYWGANZNH-UHFFFAOYSA-N 0.000 description 1
- PERPNFLGJXUDDW-YHDCXSKOSA-N Astringin Natural products OC[C@@H]1O[C@H](Oc2cc(O)cc(C=Cc3ccc(O)c(O)c3)c2)[C@H](O)[C@@H](O)[C@@H]1O PERPNFLGJXUDDW-YHDCXSKOSA-N 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- NTPAXPJSBGILOW-ZIKNSQGESA-N C(\C=C\C1=CC=C(C=C1)O)(=O)O.C(C=CC1=CC=CC=C1)(=O)O Chemical compound C(\C=C\C1=CC=C(C=C1)O)(=O)O.C(C=CC1=CC=CC=C1)(=O)O NTPAXPJSBGILOW-ZIKNSQGESA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- HDOMLWFFJSLFBI-UHFFFAOYSA-N Eriocitrin Natural products CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(Oc4c3)c5ccc(OC6OC(COC7OC(C)C(O)C(O)C7O)C(O)C(O)C6O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O HDOMLWFFJSLFBI-UHFFFAOYSA-N 0.000 description 1
- OMQADRGFMLGFJF-MNPJBKLOSA-N Eriodictioside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=C(O)C(O)=CC=2)O1 OMQADRGFMLGFJF-MNPJBKLOSA-N 0.000 description 1
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 1
- 229920000296 Glucogallin Polymers 0.000 description 1
- OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- YNOCUODOFOEIFZ-UHFFFAOYSA-N Hydroxymatairesinol Natural products C1=C(O)C(OC)=CC=C1CC1C(=O)OCC1C(O)C1=CC=C(OC)C(O)=C1 YNOCUODOFOEIFZ-UHFFFAOYSA-N 0.000 description 1
- ZHLWCBHWYUISFY-UHFFFAOYSA-N Hydroxyphenylpyruvic acid Chemical compound OC(=O)C(=O)C(O)C1=CC=CC=C1 ZHLWCBHWYUISFY-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- QURCVMIEKCOAJU-HWKANZROSA-N Isoferulic acid Natural products COC1=CC=C(\C=C\C(O)=O)C=C1O QURCVMIEKCOAJU-HWKANZROSA-N 0.000 description 1
- NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- MIEILDYWGANZNH-DSQUFTABSA-N L-arogenic acid Chemical compound OC(=O)[C@@H](N)CC1(C(O)=O)C=CC(O)C=C1 MIEILDYWGANZNH-DSQUFTABSA-N 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- YVRYZXAHRGGELT-UHFFFAOYSA-N Lariciresinol Natural products C1=C2OCOC2=CC(C2C(C)C3(OC)C=C(CC=C)C(=O)CC3(O2)OC)=C1 YVRYZXAHRGGELT-UHFFFAOYSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- KMRMUZKLFIEVAO-RKDXNWHRSA-N Myrtenal Natural products C1[C@H]2C(C)(C)[C@@H]1CC=C2C=O KMRMUZKLFIEVAO-RKDXNWHRSA-N 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- RINSJDWDXSWUOK-UHFFFAOYSA-N OC(=O)C1=CC=C(O)C(O)=C1.OC(=O)C1=CC=C(O)C(O)=C1 Chemical compound OC(=O)C1=CC=C(O)C(O)=C1.OC(=O)C1=CC=C(O)C(O)=C1 RINSJDWDXSWUOK-UHFFFAOYSA-N 0.000 description 1
- QKTAFNAZTCSZGF-UHFFFAOYSA-N OC(=O)C1=CC=C(O)C=C1O.OC(=O)C1=CC=C(O)C=C1O Chemical compound OC(=O)C1=CC=C(O)C=C1O.OC(=O)C1=CC=C(O)C=C1O QKTAFNAZTCSZGF-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-DARKYYSBSA-N Phloridzin Natural products O[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-DARKYYSBSA-N 0.000 description 1
- IIXHQGSINFQLRR-UHFFFAOYSA-N Piceatannol Natural products Oc1ccc(C=Cc2c(O)c(O)c3CCCCc3c2O)cc1O IIXHQGSINFQLRR-UHFFFAOYSA-N 0.000 description 1
- HSTZMXCBWJGKHG-CENDIDJXSA-N Piceid Natural products OC[C@@H]1O[C@@H](Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2)[C@H](O)[C@H](O)[C@H]1O HSTZMXCBWJGKHG-CENDIDJXSA-N 0.000 description 1
- FGUBFGWYEYFGRK-HNNXBMFYSA-N Pinocembrin Natural products Cc1cc(C)c2C(=O)C[C@H](Oc2c1)c3ccccc3 FGUBFGWYEYFGRK-HNNXBMFYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 1
- XJTXBUKLGQCZHC-UHFFFAOYSA-N Steganacin Natural products C1=C2C=3C(OC)=C(OC)C(OC)=CC=3CC3C(=O)OCC3C(OC(C)=O)C2=CC2=C1OCO2 XJTXBUKLGQCZHC-UHFFFAOYSA-N 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical group C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical group C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical group C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- JACRWUWPXAESPB-QMMMGPOBSA-N Tropic acid Natural products OC[C@H](C(O)=O)C1=CC=CC=C1 JACRWUWPXAESPB-QMMMGPOBSA-N 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- CGQCWMIAEPEHNQ-UHFFFAOYSA-N Vanillylmandelic acid Chemical compound COC1=CC(C(O)C(O)=O)=CC=C1O CGQCWMIAEPEHNQ-UHFFFAOYSA-N 0.000 description 1
- GPVDHNVGGIAOQT-UHFFFAOYSA-N Veratric acid Natural products COC1=CC=C(C(O)=O)C(OC)=C1 GPVDHNVGGIAOQT-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- NESNOMLNDJUFBJ-UHFFFAOYSA-N alpha-Viniferin Natural products Oc1ccc(cc1)C2Oc3cc(O)cc4C5C(Oc6cc(O)cc(C7C(Oc8cc(O)cc(C2c34)c78)c9cccc(O)c9)c56)c%10cccc(O)c%10 NESNOMLNDJUFBJ-UHFFFAOYSA-N 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- LHUHHURKGTUZHU-UHFFFAOYSA-N ampelopsin A Natural products C12=C(O)C=C(O)C=C2C(C=23)C(C=4C=CC(O)=CC=4)OC3=CC(O)=CC=2C(O)C1C1=CC=C(O)C=C1 LHUHHURKGTUZHU-UHFFFAOYSA-N 0.000 description 1
- LHUHHURKGTUZHU-QWMXJGQVSA-N ampelopsin a Chemical compound C1([C@@H]2[C@H](C=3C=C(O)C=C4O[C@@H]([C@H](C=34)C3=CC(O)=CC(O)=C32)C=2C=CC(O)=CC=2)O)=CC=C(O)C=C1 LHUHHURKGTUZHU-QWMXJGQVSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- NWCHELUCVWSRRS-UHFFFAOYSA-N atrolactic acid Chemical compound OC(=O)C(O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 229930015036 aurone Natural products 0.000 description 1
- 150000001530 aurones Chemical class 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- GCAIEATUVJFSMC-UHFFFAOYSA-N benzene-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1C(O)=O GCAIEATUVJFSMC-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GDVRUDXLQBVIKP-UHFFFAOYSA-N beta-D-glucogallin Natural products OC1C(O)C(O)C(CO)OC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229930007646 carveol Natural products 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 150000001789 chalcones Chemical class 0.000 description 1
- PXUKGIXMZKRNMI-VCEXAHOOSA-N chembl1939277 Chemical compound C1=CC(O)=CC=C1[C@H]1[C@H](C=2C=C(O)C=C(O)C=2)C2=C([C@H]3[C@@H](C4=C(O)C=C5O[C@@H]([C@H]6C7=CC(O)=CC(O)=C7[C@H](C=7C=CC(O)=CC=7)[C@H]3C4=C65)C=3C=CC(O)=CC=3)C=3C=CC(O)=CC=3)C=C(O)C=C2O1 PXUKGIXMZKRNMI-VCEXAHOOSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- FQWLMRXWKZGLFI-UHFFFAOYSA-N cis epsilon-viniferine Natural products C1=CC(O)=CC=C1C=CC1=CC(O)=CC2=C1C(C=1C=C(O)C=C(O)C=1)C(C=1C=CC(O)=CC=1)O2 FQWLMRXWKZGLFI-UHFFFAOYSA-N 0.000 description 1
- NPFVOOAXDOBMCE-PLNGDYQASA-N cis-3-Hexenyl acetate Natural products CC\C=C/CCOC(C)=O NPFVOOAXDOBMCE-PLNGDYQASA-N 0.000 description 1
- RRGOKSYVAZDNKR-ARJAWSKDSA-M cis-3-hexenylacetate Chemical compound CC\C=C/CCCC([O-])=O RRGOKSYVAZDNKR-ARJAWSKDSA-M 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229940119526 coniferyl alcohol Drugs 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical group C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- ZVIJTQFTLXXGJA-UHFFFAOYSA-N dihydroisoferulic acid Chemical compound COC1=CC=C(CCC(O)=O)C=C1O ZVIJTQFTLXXGJA-UHFFFAOYSA-N 0.000 description 1
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- WTOYNNBCKUYIKC-UHFFFAOYSA-N dl-nootkatone Natural products C1CC(C(C)=C)CC2(C)C(C)CC(=O)C=C21 WTOYNNBCKUYIKC-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
- SXRAUGAFMDOHKN-UHFFFAOYSA-N epsilon-viniferin Natural products CC1(Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2C1(C)c4cc(O)cc(O)c4)c5ccc(O)cc5 SXRAUGAFMDOHKN-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 1
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 1
- 235000011797 eriodictyol Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229930003487 europinidin Natural products 0.000 description 1
- XJXMPIWHBIOJSH-UHFFFAOYSA-O europinidin Chemical compound OC1=C(O)C(OC)=CC(C=2C(=CC=3C(OC)=CC(O)=CC=3[O+]=2)O)=C1 XJXMPIWHBIOJSH-UHFFFAOYSA-O 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229930193974 gastrodin Natural products 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- SXFWLVJIOLHNNS-UHFFFAOYSA-N gnetin H Natural products CC1(Oc2cc3OC(C)(c4ccc(O)cc4)C(C)(c5cc(O)cc(O)c5)c3c(C=Cc6ccc(O)cc6)c2C1(C)c7cc(O)cc(O)c7)c8ccc(O)cc8 SXFWLVJIOLHNNS-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 1
- PXUKGIXMZKRNMI-UHFFFAOYSA-N hemsleyanol D Natural products C1=CC(O)=CC=C1C1C(C=2C=C(O)C=C(O)C=2)C2=C(C3C(C4=C(O)C=C5OC(C6C7=CC(O)=CC(O)=C7C(C=7C=CC(O)=CC=7)C3C4=C65)C=3C=CC(O)=CC=3)C=3C=CC(O)=CC=3)C=C(O)C=C2O1 PXUKGIXMZKRNMI-UHFFFAOYSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 description 1
- YQQUILZPDYJDQJ-KGDQSQJYSA-N hopeaphenol Chemical compound C1=CC(O)=CC=C1[C@H](O1)[C@@H]2C3=CC(O)=CC(O)=C3[C@@H](C=3C=CC(O)=CC=3)[C@H]([C@@H]3C=4C=C(O)C=C5O[C@H]([C@@H](C=45)C4=CC(O)=CC(O)=C4[C@H]3C=3C=CC(O)=CC=3)C=3C=CC(O)=CC=3)C3=C2C1=CC(O)=C3 YQQUILZPDYJDQJ-KGDQSQJYSA-N 0.000 description 1
- YQQUILZPDYJDQJ-PLGGFYDZSA-N hopeaphenol Natural products Oc1ccc(cc1)[C@@H]2Oc3cc(O)cc4[C@H]([C@@H]5[C@@H](c6ccc(O)cc6)c7c(O)cc(O)cc7[C@@H]8[C@H](Oc9cc(O)cc5c89)c%10ccc(O)cc%10)[C@@H](c%11ccc(O)cc%11)c%12c(O)cc(O)cc%12[C@@H]2c34 YQQUILZPDYJDQJ-PLGGFYDZSA-N 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- UKHWOLNMBQSCLJ-BIENJYKASA-N hydroxymatairesinol Chemical compound C1=C(O)C(OC)=CC(C[C@H]2C(OC[C@@H]2[C@H](O)C=2C=C(OC)C(O)=CC=2)=O)=C1 UKHWOLNMBQSCLJ-BIENJYKASA-N 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 235000003248 hydroxytyrosol Nutrition 0.000 description 1
- 229940095066 hydroxytyrosol Drugs 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940076263 indole Drugs 0.000 description 1
- HAJKHJOABGFIGP-UHFFFAOYSA-N indolizidine Chemical compound C1CCCN2CCCC21 HAJKHJOABGFIGP-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- NNQSGBRGJHSRFN-UHFFFAOYSA-N isoflavan Chemical class C1OC2=CC=CC=C2CC1C1=CC=CC=C1 NNQSGBRGJHSRFN-UHFFFAOYSA-N 0.000 description 1
- 235000002324 isoflavanes Nutrition 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- BWXLCOBSWMQCGP-UHFFFAOYSA-N isohomovanillic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1O BWXLCOBSWMQCGP-UHFFFAOYSA-N 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 235000006826 lariciresinol Nutrition 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 229930013978 luteolinidin Natural products 0.000 description 1
- GDNIGMNXEKGFIP-UHFFFAOYSA-O luteolinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=CC=1C1=CC=C(O)C(O)=C1 GDNIGMNXEKGFIP-UHFFFAOYSA-O 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 235000000055 matairesinol Nutrition 0.000 description 1
- RNXYRAQIZQGUIK-UHFFFAOYSA-N matairesinol Natural products COc1cc(CC2OCC(=O)C2Cc3ccc(O)c(OC)c3)ccc1O RNXYRAQIZQGUIK-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- OGFXBIXJCWAUCH-UHFFFAOYSA-N meso-secoisolariciresinol Natural products C1=2C=C(O)C(OC)=CC=2CC(CO)C(CO)C1C1=CC=C(O)C(OC)=C1 OGFXBIXJCWAUCH-UHFFFAOYSA-N 0.000 description 1
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- 229930014802 neoflavonoid Natural products 0.000 description 1
- 150000002804 neoflavonoids Chemical class 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- DQRZXILSJKXVQV-UHFFFAOYSA-N nepalensinol G Natural products Oc1ccc(cc1)C2OC3=CC(=O)C(=O)C4=C3C2c5cc(O)cc(O)c5C(C4C6C(c7ccc(O)cc7)c8c(O)cc(O)cc8C9C(Oc%10cc(O)cc6c9%10)c%11ccc(O)cc%11)c%12ccc(O)cc%12 DQRZXILSJKXVQV-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- TZPBMNKOLMSJPF-UHFFFAOYSA-N o-O-beta-D-glucosylbenzoic acid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1C(O)=O TZPBMNKOLMSJPF-UHFFFAOYSA-N 0.000 description 1
- ILUJQPXNXACGAN-UHFFFAOYSA-N ortho-methoxybenzoic acid Natural products COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- IAFPTKYDGNATOK-UHFFFAOYSA-N pentazinane Chemical group N1NNNNC1 IAFPTKYDGNATOK-UHFFFAOYSA-N 0.000 description 1
- ALAGDBVXZZADSN-UHFFFAOYSA-N pentazine Chemical group C1=NN=NN=N1 ALAGDBVXZZADSN-UHFFFAOYSA-N 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 1
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 1
- 229930182487 phenolic glycoside Natural products 0.000 description 1
- 150000007950 phenolic glycosides Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- HSTZMXCBWJGKHG-OUUBHVDSSA-N piceide Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-OUUBHVDSSA-N 0.000 description 1
- URFCJEUYXNAHFI-ZDUSSCGKSA-N pinocembrin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=CC=C1 URFCJEUYXNAHFI-ZDUSSCGKSA-N 0.000 description 1
- 235000007221 pinoresinol Nutrition 0.000 description 1
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 description 1
- YCVPRTHEGLPYPB-UHFFFAOYSA-N pinosylvine Natural products OC1=CC(O)=CC(C=CC=2C=CC=CC=2)=C1 YCVPRTHEGLPYPB-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
- 229960001237 podophyllotoxin Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 229930008679 prenylflavonoid Natural products 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- VLEUZFDZJKSGMX-ONEGZZNKSA-N pterostilbene Chemical compound COC1=CC(OC)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-ONEGZZNKSA-N 0.000 description 1
- VLEUZFDZJKSGMX-UHFFFAOYSA-N pterostilbene Natural products COC1=CC(OC)=CC(C=CC=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-UHFFFAOYSA-N 0.000 description 1
- PMXCMJLOPOFPBT-HNNXBMFYSA-N purvalanol A Chemical compound C=12N=CN(C(C)C)C2=NC(N[C@@H](CO)C(C)C)=NC=1NC1=CC=CC(Cl)=C1 PMXCMJLOPOFPBT-HNNXBMFYSA-N 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- LJPZHJUSICYOIX-UHFFFAOYSA-N quinolizidine Chemical compound C1CCCC2CCCCN21 LJPZHJUSICYOIX-UHFFFAOYSA-N 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical group C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- BNUZUOWRDKPBQR-UHFFFAOYSA-N reticuline Natural products CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(O)=C1 BNUZUOWRDKPBQR-UHFFFAOYSA-N 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- 229930002286 rosinidin Natural products 0.000 description 1
- GNONHFYAESLOCB-UHFFFAOYSA-O rosinidin Chemical compound [O+]=1C2=CC(OC)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(OC)=C1 GNONHFYAESLOCB-UHFFFAOYSA-O 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 235000004239 secoisolariciresinol Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 description 1
- KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- XJTXBUKLGQCZHC-GCKMJXCFSA-N steganacin Chemical compound C1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@@H]3C(=O)OC[C@H]3[C@H](OC(C)=O)C2=CC2=C1OCO2 XJTXBUKLGQCZHC-GCKMJXCFSA-N 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- KOWMJRJXZMEZLD-UHFFFAOYSA-N syringaresinol Chemical compound COC1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 KOWMJRJXZMEZLD-UHFFFAOYSA-N 0.000 description 1
- LVUPFEOCDSHRBL-UHFFFAOYSA-N syringaresinol Natural products COc1cccc(OC)c1C2OCC3C2COC3c4c(OC)cccc4OC LVUPFEOCDSHRBL-UHFFFAOYSA-N 0.000 description 1
- NPFVOOAXDOBMCE-UHFFFAOYSA-N trans-3-hexenyl acetate Natural products CCC=CCCOC(C)=O NPFVOOAXDOBMCE-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- PERPNFLGJXUDDW-CUYWLFDKSA-N trans-astringin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(\C=C\C=2C=C(O)C(O)=CC=2)=C1 PERPNFLGJXUDDW-CUYWLFDKSA-N 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- PTNLHDGQWUGONS-OWOJBTEDSA-N trans-p-coumaryl alcohol Chemical compound OC\C=C\C1=CC=C(O)C=C1 PTNLHDGQWUGONS-OWOJBTEDSA-N 0.000 description 1
- HSTZMXCBWJGKHG-CUYWLFDKSA-N trans-piceid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-CUYWLFDKSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- WCTNXGFHEZQHDR-UHFFFAOYSA-N valencene Natural products C1CC(C)(C)C2(C)CC(C(=C)C)CCC2=C1 WCTNXGFHEZQHDR-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- DGNAGJFHEJITCF-IUAFFJJUSA-N vaticanol B Natural products Oc1ccc(cc1)[C@@H]2Oc3cc(O)c4[C@@H]([C@H]([C@@H]5[C@H](c6ccc(O)cc6)c7c(O)cc(O)cc7[C@@H]2c3c45)c8ccccc8)c9cc(O)cc%10O[C@@H]([C@@H](c%11cc(O)cc(O)c%11)c9%10)c%12ccc(O)cc%12 DGNAGJFHEJITCF-IUAFFJJUSA-N 0.000 description 1
- VOANMQWFRWOKSM-ATGKYDEGSA-N vaticanol b Chemical compound C1=CC(O)=CC=C1[C@H]1[C@H](C=2C=C(O)C=C(O)C=2)C2=C([C@H]3C4=C(O)C=C5O[C@H]([C@@H]6C7=CC(O)=CC(O)=C7[C@@H](C=7C=CC(O)=CC=7)[C@H](C4=C65)[C@@H]3C=3C=CC(O)=CC=3)C=3C=CC(O)=CC=3)C=C(O)C=C2O1 VOANMQWFRWOKSM-ATGKYDEGSA-N 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
本発明は、4-ヒドロキシ安息香酸またはその誘導体の製造方法および化成品の製造方法に関するものである。 The present invention relates to a method for producing 4-hydroxybenzoic acid or a derivative thereof and a method for producing a chemical product.
芳香族カルボン酸化合物のような環式化合物は、例えばエンジニアリングプラスチックのような樹脂や薬品の原料の他、香料や化粧料またはそれらの原料として用いられている。 Cyclic compounds such as aromatic carboxylic acid compounds are used, for example, as raw materials for resins such as engineering plastics and pharmaceuticals, as well as for fragrances and cosmetics, or as raw materials for these.
このような環式化合物は、従来、石油、天然ガスおよび石炭のような化石資源を原料として製造される。また、近年では、化石資源の枯渇や二酸化炭素濃度の増加に伴う地球温暖化への懸念から、バイオマス資源を原料とすることが試みられている。 Such cyclic compounds are traditionally produced using fossil resources such as petroleum, natural gas, and coal as raw materials. In recent years, however, there have been attempts to use biomass resources as raw materials due to concerns over global warming caused by the depletion of fossil resources and the increase in carbon dioxide concentrations.
例えば、特許文献1には、バイオマスから微生物発酵によりメタンを製造した後、触媒反応によってメタンからベンゼンを製造し、さらにこのベンゼンからベンゼン誘導体を製造する方法が開示されている。このようにして製造されたベンゼン誘導体は、芳香族ポリマーの原料として用いられるため、化石資源に依存しないポリマーを実現することができる。 For example, Patent Document 1 discloses a method of producing methane from biomass by microbial fermentation, producing benzene from the methane by a catalytic reaction, and then producing a benzene derivative from the benzene. The benzene derivative produced in this way is used as a raw material for aromatic polymers, making it possible to realize polymers that are not dependent on fossil resources.
しかしながら、従来の方法は、ベンゼン誘導体の製造効率がまだ十分ではない。具体的には、バイオマスからメタンおよびベンゼンを経てベンゼン誘導体(例えばフタル酸等)を製造するため、投入する手間やエネルギーの割に、合成されるベンゼン誘導体の量が少ないという問題がある。 However, the conventional methods are still not efficient enough in producing benzene derivatives. Specifically, because benzene derivatives (such as phthalic acid) are produced from biomass via methane and benzene, there is a problem that the amount of benzene derivatives synthesized is small compared to the effort and energy input.
また、製造されるベンゼン誘導体の純度を高めることも求められている。特許文献1にはベンゼンを蒸留法等で精製することが開示されており、これによってベンゼン誘導体の純度を高めることが可能であるものの、その際にはやはり多くのエネルギーを消費する。 There is also a demand for increasing the purity of the benzene derivatives produced. Patent Document 1 discloses purifying benzene using a method such as distillation, which can increase the purity of the benzene derivatives, but this still consumes a lot of energy.
本発明の目的は、固体で高純度の4-ヒドロキシ安息香酸またはその誘導体を高い収率で製造可能な製造方法、および、高品質な化成品を製造する化成品の製造方法を提供することにある。 An object of the present invention is to provide a production method capable of producing solid, high-purity 4-hydroxybenzoic acid or a derivative thereof in a high yield, and a production method for chemical products capable of producing high-quality chemical products.
このような目的は、下記(1)~(8)の本発明により達成される。
(1) 4-ヒドロキシ安息香酸またはその誘導体を含有する原料液体を、80kPa以下の圧力下において加熱された伝熱面に繰り返し接触させ、20~90℃に加熱する操作を行うことにより、前記原料液体に含まれる溶媒を蒸発させて、前記原料液体を濃縮する濃縮工程と、
濃縮された前記原料液体100gに対して活性炭を0.01~3g添加する活性炭処理を施す活性炭処理工程と、
前記活性炭処理が施された前記原料液体のpHを温度20~60℃の範囲で変化させる晶析処理を施し、前記原料液体の溶質を固体として析出させる晶析工程と、
前記原料液体から前記固体を粉末として回収する固液分離工程と、
を有することを特徴とする4-ヒドロキシ安息香酸またはその誘導体の製造方法。
These objects can be achieved by the present invention described below in (1) to (8) .
(1) a concentration step of repeatedly contacting a raw material liquid containing 4-hydroxybenzoic acid or a derivative thereof with a heated heat transfer surface under a pressure of 80 kPa or less and heating the raw material liquid to 20 to 90° C. , thereby evaporating a solvent contained in the raw material liquid and concentrating the raw material liquid;
an activated carbon treatment step of adding 0.01 to 3 g of activated carbon to 100 g of the concentrated raw liquid;
a crystallization step in which the pH of the raw material liquid that has been treated with activated carbon is changed at a temperature in the range of 20 to 60° C. to cause the solute in the raw material liquid to precipitate as a solid;
a solid-liquid separation step of recovering the solid as a powder from the raw material liquid;
The present invention relates to a method for producing 4-hydroxybenzoic acid or a derivative thereof.
(2) 前記濃縮工程は、減圧操作と常圧復帰操作とを繰り返す処理を含む上記(1)に記載の4-ヒドロキシ安息香酸またはその誘導体の製造方法。 (2) The method for producing 4-hydroxybenzoic acid or a derivative thereof according to the above (1), wherein the concentrating step includes repeating a process of reducing pressure and a process of returning to normal pressure.
(3) 前記晶析工程は、種晶を添加する操作を含む上記(1)または(2)に記載の4-ヒドロキシ安息香酸またはその誘導体の製造方法。 (3) The method for producing 4-hydroxybenzoic acid or a derivative thereof according to the above (1) or (2) , wherein the crystallization step includes an operation of adding seed crystals .
(4) 前記活性炭処理の温度は、30~150℃である上記(1)ないし(3)のいずれかに記載の4-ヒドロキシ安息香酸またはその誘導体の製造方法。 (4) The method for producing 4-hydroxybenzoic acid or a derivative thereof according to any one of (1) to (3) above, wherein the temperature of the activated carbon treatment is 30 to 150° C.
(5) 前記固液分離工程は、前記原料液体から前記固体をろ過分離する工程である上記(1)ないし(4)のいずれかに記載の4-ヒドロキシ安息香酸またはその誘導体の製造方法。 (5) The method for producing 4-hydroxybenzoic acid or a derivative thereof according to any one of (1) to (4) above, wherein the solid-liquid separation step is a step of filtering and separating the solid from the raw material liquid.
(6) バイオマスから前記原料液体を調製する原料液体調製工程をさらに有する上記(1)ないし(5)のいずれかに記載の4-ヒドロキシ安息香酸またはその誘導体の製造方法。 (6) The method for producing 4-hydroxybenzoic acid or a derivative thereof according to any one of (1) to (5) above, further comprising a raw material liquid preparation step of preparing the raw material liquid from biomass.
(7) 前記粉末は、JIS P 8148:2001に規定されたISO白色度の試験方法に準じて測定されたISO白色度が70%以上である上記(1)ないし(6)のいずれかに記載の4-ヒドロキシ安息香酸またはその誘導体の製造方法。 (7) The method for producing 4-hydroxybenzoic acid or a derivative thereof according to any one of (1) to (6) , wherein the powder has an ISO whiteness of 70% or more as measured in accordance with the ISO whiteness test method specified in JIS P 8148: 2001.
(8) 上記(1)ないし(7)のいずれかに記載の4-ヒドロキシ安息香酸またはその誘導体の製造方法を含むことを特徴とする化成品の製造方法。 (8) A method for producing a chemical product , comprising the method for producing 4-hydroxybenzoic acid or a derivative thereof according to any one of (1) to (7) above.
本発明によれば、固体で高純度の4-ヒドロキシ安息香酸またはその誘導体を高い収率で製造することができる。
また、本発明によれば、高品質な化成品を高い収率で製造することができる。
According to the present invention, it is possible to produce solid, highly pure 4-hydroxybenzoic acid or a derivative thereof in high yield.
Furthermore , according to the present invention, high-quality chemical products can be produced in high yields .
以下、本発明の環式化合物またはその誘導体の製造方法、環式化合物またはその誘導体、および化成品について添付図面に示す好適実施形態に基づいて詳細に説明する。 The method for producing the cyclic compound or its derivative, the cyclic compound or its derivative, and the chemical product of the present invention will be described in detail below based on the preferred embodiment shown in the attached drawings.
<環式化合物またはその誘導体の製造方法>
まず、本発明の環式化合物またはその誘導体の製造方法の実施形態について説明する。
<Method for producing cyclic compound or derivative thereof>
First, an embodiment of the method for producing the cyclic compound or a derivative thereof of the present invention will be described.
図1は、本発明の環式化合物またはその誘導体の製造方法の実施形態を説明するための工程図である。 Figure 1 is a process diagram illustrating an embodiment of the method for producing a cyclic compound or a derivative thereof of the present invention.
本実施形態に係る環式化合物またはその誘導体の製造方法(以下、省略して「環式化合物の製造方法」という。)は、バイオマスから原料液体を調製する原料液体調製工程S01と、原料液体を濃縮する濃縮工程S02と、原料液体を活性炭に接触させる活性炭処理工程S03と、原料液体に晶析処理を施し前記原料液体の溶質を固体として析出させる晶析工程S04と、原料液体から固体の環式化合物またはその誘導体を回収する固液分離工程S05と、を有する。このような環式化合物の製造方法によれば、固体で高純度の環式化合物またはその誘導体を高い収率で製造することができる。 The method for producing a cyclic compound or a derivative thereof according to this embodiment (hereinafter, abbreviated as "method for producing a cyclic compound") includes a raw liquid preparation step S01 for preparing a raw liquid from biomass, a concentration step S02 for concentrating the raw liquid, an activated carbon treatment step S03 for contacting the raw liquid with activated carbon, a crystallization step S04 for subjecting the raw liquid to a crystallization process to precipitate the solute of the raw liquid as a solid, and a solid-liquid separation step S05 for recovering a solid cyclic compound or a derivative thereof from the raw liquid. According to this method for producing a cyclic compound, a solid, high-purity cyclic compound or a derivative thereof can be produced with a high yield.
以下、各工程について順次説明する。なお、以下の説明では、環式化合物またはその誘導体を省略して「環式化合物」ともいう。 Each step will be explained below. In the following explanation, cyclic compounds or their derivatives will be abbreviated to "cyclic compounds."
(原料液体調製工程S01)
国際公開公報WO2015/156271記載の方法でバイオマスから原料液体を調製する。
(Raw material liquid preparation step S01)
A raw material liquid is prepared from biomass by the method described in International Publication WO2015/156271.
(濃縮工程S02)
次に、得られた原料液体を濃縮する。原料液体としては、前述した糖類と形質転換体との反応物を含む液体が挙げられる。
(Concentration step S02)
Next, the obtained raw liquid is concentrated. Examples of the raw liquid include the liquid containing the reaction product between the above-mentioned sugars and the transformant.
濃縮方法には、例えば、蒸留、吸着、抽出、膜分離、透析、逆浸透等が挙げられ、これらのうちの1種または2種以上が組み合わされて用いられる。 Concentration methods include, for example, distillation, adsorption, extraction, membrane separation, dialysis, reverse osmosis, etc., and one or more of these may be used in combination.
このうち、濃縮工程は、加熱された伝熱面に原料液体を接触させ、原料液体に含まれる溶媒を蒸発させる工程であって、伝熱面に原料液体を繰り返し接触させる工程であるのが好ましい。このような工程によれば、原料液体に含まれる溶媒を蒸発させる際、原料液体によって伝熱面を常時濡らすことができるので、焦げの発生を抑制することができる。 Of these, the concentration process is a process in which the raw liquid is brought into contact with a heated heat transfer surface to evaporate the solvent contained in the raw liquid, and is preferably a process in which the raw liquid is repeatedly brought into contact with the heat transfer surface. According to such a process, the heat transfer surface can be constantly wetted with the raw liquid when the solvent contained in the raw liquid is evaporated, so that the occurrence of scorching can be suppressed.
具体的には、内壁面が伝熱面になっている撹拌槽に原料液体を入れ、底部に溜まった原料液体を汲み上げ、内壁面に散布しつつ原料液体を撹拌する装置が用いつつ、濃縮すればよい。これにより、伝熱面の有効面積を最大限に利用することができ、濃縮効率を高めることができる。また、伝熱面が乾燥することによる焦げの発生が抑制され、析出する固体の着色を抑制することができる。 Specifically, the raw liquid is placed in a mixing tank whose inner wall surface is a heat transfer surface, and the raw liquid that has accumulated at the bottom is pumped up and concentrated using a device that stirs the raw liquid while spraying it on the inner wall surface. This makes it possible to make maximum use of the effective area of the heat transfer surface, and increases the concentration efficiency. It also prevents the heat transfer surface from drying out and prevents the coloring of the precipitated solid.
濃縮工程における加熱温度は、特に限定されないが、15~120℃程度であるのが好ましく、20~90℃程度であるのがより好ましい。これにより、焦げの発生や溶質の変性等を抑えつつ、濃縮の効率を高めることができる。 The heating temperature in the concentration step is not particularly limited, but is preferably about 15 to 120°C, and more preferably about 20 to 90°C. This increases the efficiency of concentration while suppressing the occurrence of scorching and denaturation of solutes.
また、濃縮工程における原料溶液は、減圧下に置かれるようにしてもよい。これにより、溶媒の揮発が促進され、濃縮効率を高めることができる。原料溶液が置かれる環境の圧力は、特に限定されないが、80kPa以下であるのが好ましく、0.1~50kPaであるのがより好ましい。 The raw material solution in the concentration step may be placed under reduced pressure. This promotes evaporation of the solvent and increases the concentration efficiency. There are no particular limitations on the pressure of the environment in which the raw material solution is placed, but it is preferably 80 kPa or less, and more preferably 0.1 to 50 kPa.
なお、濃縮にあたっては、塩基性物質を用いて環式化合物の塩を調製し、水性媒体に溶解させるようにしてもよい。
また、濃縮工程は必要に応じて行えばよく、省略されてもよい。
For the concentration, a salt of the cyclic compound may be prepared using a basic substance, and then dissolved in an aqueous medium.
Furthermore, the concentration step may be carried out as necessary and may be omitted.
なお、原料液体を濃縮することにより、原料液体の単位量から回収可能な固体の量の割合(収率)を高めることができる。このため、後述する晶析工程に要する時間やエネルギーを削減することができ、固体の製造効率(単位時間当たりの固体の生産能力)を高めることができる。 In addition, by concentrating the raw liquid, the ratio (yield) of the amount of solids that can be recovered from a unit amount of raw liquid can be increased. This makes it possible to reduce the time and energy required for the crystallization process described below, and to increase the production efficiency of solids (production capacity of solids per unit time).
なお、濃縮工程では、濃縮の進行に伴って濃縮効率が徐々に低下するおそれがある。このような問題を踏まえ、本工程では、必要に応じて、濃縮の最中に減圧操作と常圧復帰操作とを繰り返す処理を施すようにしてもよい。これにより、気泡の収縮と膨張とが生じ、含まれる気泡の上昇、破裂が促されるため、気泡を効率よく消滅させることができる。その結果、濃縮効率の低下を抑えることができる。 In the concentration process, there is a risk that the concentration efficiency will gradually decrease as the concentration progresses. In consideration of this problem, in this process, if necessary, a process of repeatedly reducing pressure and returning to normal pressure may be performed during the concentration. This causes the air bubbles to contract and expand, encouraging the bubbles to rise and burst, thereby efficiently eliminating the air bubbles. As a result, the decrease in concentration efficiency can be suppressed.
減圧操作における圧力は、特に限定されないが、0.1~100kPa程度であるのが好ましく、1~80kPa程度であるのがより好ましい。これにより、含まれる気泡を効率よく上昇させ、破裂させることができ、濃縮効率の低下を十分に抑えつつ、濃縮を促進させることができる。 The pressure in the decompression operation is not particularly limited, but is preferably about 0.1 to 100 kPa, and more preferably about 1 to 80 kPa. This allows the contained air bubbles to rise and burst efficiently, and promotes concentration while sufficiently suppressing a decrease in concentration efficiency.
また、減圧操作の時間と常圧復帰操作の時間の比率は、気泡の発生の程度や濃縮速度に応じて適宜調整されるが、一例として、1:10~10:1程度であるのが好ましい。これにより、効率よく気泡を除去することができる。 The ratio of the time for the depressurization operation to the time for the normal pressure return operation is adjusted appropriately depending on the degree of bubble generation and the concentration speed, but as an example, it is preferable for it to be about 1:10 to 10:1. This allows for efficient removal of bubbles.
また、減圧操作の時間は、特に限定されないが、一例として1~10秒程度であるのが好ましい。これにより、効率よく気泡を除去することができる。 The time for the decompression operation is not particularly limited, but is preferably about 1 to 10 seconds, for example. This allows air bubbles to be removed efficiently.
(活性炭処理工程S03)
次に、原料液体に活性炭処理を施す。
(Activated carbon treatment step S03)
Next, the raw liquid is subjected to activated carbon treatment.
原料液体に活性炭を添加し、撹拌する。これにより、原料液体の溶質について脱色することができる。 Activated carbon is added to the raw liquid and stirred. This allows the solutes in the raw liquid to be decolorized.
なお、活性炭処理の温度は、30~150℃程度であるのが好ましい。また、活性炭処理の時間は、特に限定されないが、10分~10時間程度であるのが好ましい。 The temperature for the activated carbon treatment is preferably about 30 to 150°C. The time for the activated carbon treatment is not particularly limited, but is preferably about 10 minutes to 10 hours.
また、原料液体100gに対する活性炭の添加量は、特に限定されないが、0.01~3gであるのが好ましく、0.1~1gであるのがより好ましい。これにより、溶質までが活性炭に吸着されてしまうのを抑制しつつ、十分な脱色作用を享受することができる。
なお、活性炭処理は必要に応じて行えばよく、省略されてもよい。
The amount of activated carbon added per 100 g of raw liquid is not particularly limited, but is preferably 0.01 to 3 g, and more preferably 0.1 to 1 g, which can suppress the solute from being adsorbed by the activated carbon while providing a sufficient decolorizing effect.
The activated carbon treatment may be carried out as necessary and may be omitted.
(晶析工程S04)
次に、原料液体に晶析処理を施し、原料液体の溶質を固体として析出させる。このような晶析処理によれば、溶液中の溶質の溶解度を下げることによって固体を析出させるというプロセスを経るため、その後の固液分離工程を経ることによって純度の高い固体の物質を回収することができる。このため、日用品、化粧品、医薬品、食品の原料等として有用な環式化合物を容易に製造することができる。
(Crystallization step S04)
Next, the raw liquid is subjected to a crystallization process to precipitate the solute of the raw liquid as a solid. This crystallization process involves a process in which the solubility of the solute in the solution is reduced to precipitate a solid, and a solid substance with high purity can be recovered by a subsequent solid-liquid separation process. This makes it possible to easily produce cyclic compounds that are useful as raw materials for daily necessities, cosmetics, pharmaceuticals, foods, etc.
晶析処理は、原料液体から溶質を固体として析出させる処理であれば、いかなる方法であってもよい。 The crystallization process can be any process that causes the solute to precipitate as a solid from the raw liquid.
具体的には、例えば、原料液体の温度を変化させ溶解度の温度依存性を利用して晶析する処理、加熱または減圧等の操作により原料液体から溶媒を揮発除去し晶析する処理、溶質の溶解度が低い溶媒を添加し溶解度の溶媒種依存性を利用して晶析する処理、原料溶液のpHを変化させ溶解度のpH応答性を利用して晶析する処理等が挙げられ、これらのうちの1種または複数種を組み合わせて用いられる。 Specific examples include a process in which the temperature of the raw liquid is changed to utilize the temperature dependency of solubility for crystallization, a process in which the solvent is evaporated from the raw liquid by heating or reducing pressure, etc., a process in which a solvent in which the solute has low solubility is added to utilize the solvent-type dependency of solubility for crystallization, and a process in which the pH of the raw solution is changed to utilize the pH responsiveness of solubility for crystallization, and the like. One or a combination of these processes can be used.
例えばpH応答性を利用して晶析する処理を用いる場合、溶質に含まれる環式化合物は一般に低pHにおいて水への溶解度が低下する。したがって、晶析工程においてpHを例えば1~4程度まで下げることにより、溶解度を低下させ、溶質を析出させることができる。 For example, when using a process for crystallization that utilizes pH responsiveness, the solubility of cyclic compounds contained in the solute in water generally decreases at low pH. Therefore, by lowering the pH to, for example, about 1 to 4 in the crystallization process, the solubility can be reduced and the solute can be precipitated.
このときの温度は、特に限定されないが、例えば15~80℃程度であるのが好ましく、20~60℃程度であるのがより好ましい。これにより、晶析処理の能力と収率とを両立することができる。 The temperature at this time is not particularly limited, but is preferably about 15 to 80°C, and more preferably about 20 to 60°C. This allows both the crystallization process capacity and yield to be achieved.
また、晶析操作は、バッチ操作であっても連続操作であってもよい。
また、晶析操作には、公知の撹拌槽が用いられる。
The crystallization process may be a batch process or a continuous process.
For the crystallization operation, a known stirring tank is used.
また、晶析を促進させるため、必要に応じて、析出させようとする固体の成分を含む種晶を添加するようにしてもよい。これにより、種晶が核となって晶析が促進され、晶析効率を高めるとともに、高純度化が図られやすくなる。 To promote crystallization, seed crystals containing the solid components to be precipitated may be added as necessary. This promotes crystallization with the seed crystals acting as nuclei, increasing the crystallization efficiency and facilitating high purity.
(固液分離工程S05)
次に、原料液体から固体の環式化合物を回収する。これにより、固液分離によって固体で高純度の環式化合物を効率よく回収することができる。このような環式化合物は、取り扱いが容易であるとともに、さらなる精製が不要になったり、さらなる精製に要する時間や手間を削減したりすることができるので、例えば化成品やその原料として利用しやすいものとなる。
(Solid-liquid separation step S05)
Next, the solid cyclic compound is recovered from the raw liquid. This allows the solid, high-purity cyclic compound to be efficiently recovered by solid-liquid separation. Such cyclic compounds are easy to handle and do not require further purification or can reduce the time and effort required for further purification, making them easy to use as, for example, chemical products or their raw materials.
固液分離としては、例えば、ろ過分離、沈降分離、減圧脱水、加圧脱水等が挙げられるが、特に操作の容易さや分離の正確性の観点からろ過分離が好ましく用いられる。具体的には、遠心ろ過機を用いることができる。
また、固液分離操作は、バッチ操作であっても連続操作であってもよい。
Examples of solid-liquid separation include filtration, sedimentation, dehydration under reduced pressure, and dehydration under pressure, among which filtration is preferably used from the viewpoints of ease of operation and accuracy of separation. Specifically, a centrifugal filter can be used.
The solid-liquid separation operation may be a batch operation or a continuous operation.
その後、必要に応じて、貧溶媒を用いて洗浄操作を行った後、乾燥させ、より純度の高い固体の環式化合物を回収することができる。 If necessary, the product can then be washed with a poor solvent and then dried to recover a more pure solid cyclic compound.
<環式化合物またはその誘導体>
次に、本発明の環式化合物またはその誘導体の実施形態について説明する。
<Cyclic Compound or Derivative>
Next, embodiments of the cyclic compound or a derivative thereof of the present invention will be described.
本実施形態に係る環式化合物またはその誘導体は、例えば下記式(1)で表される化合物である。 The cyclic compound or its derivative according to this embodiment is, for example, a compound represented by the following formula (1).
なお、環式化合物の誘導体とは、上記式(1)で表される化合物、上記(1)で表される化合物から誘導される化合物、および、上記式(1)で表される化合物の塩のうちのいずれか、またはこれらの2種以上が混在したものである。 The derivative of a cyclic compound is any one of the compounds represented by the above formula (1), compounds derived from the compounds represented by the above formula (1), and salts of the compounds represented by the above formula (1), or a mixture of two or more of these.
上記(1)で表される化合物から誘導される化合物としては、上記(1)で表される化合物のエステル、酸無水物、アミド、酸ハロゲン化物等が挙げられる。なお、エステルには、例えば、メチルエステル、エチルエステル、プロピルエステル、ブチルエステル等が挙げられる。 Compounds derived from the compound represented by (1) above include esters, acid anhydrides, amides, acid halides, etc. of the compound represented by (1) above. Examples of esters include methyl esters, ethyl esters, propyl esters, butyl esters, etc.
上記(1)で表される化合物の塩としては、ナトリウム塩、カリウム塩、アンモニウム塩等が挙げられる。 Examples of salts of the compound represented by (1) above include sodium salts, potassium salts, ammonium salts, etc.
また、このような環式化合物は、バイオマス由来であって、粉末状をなしているものが好ましく用いられる。これにより、環境負荷が少なく、取り扱いが容易な化成品または化成品原料を得ることができる。 In addition, such cyclic compounds are preferably derived from biomass and are in powder form. This makes it possible to obtain chemical products or chemical product raw materials that have a low environmental impact and are easy to handle.
また、かかる環式化合物は、JIS P 8148:2001に規定されたISO白色度の試験方法に準じて測定されたISO白色度が70%以上であることが好ましく、80%以上であるのがより好ましい。このような環式化合物は、不純物が少なく、化成品または化成品原料となる。特に、淡色の化成品を製造する場合等には、原料の色が化成品に移行するのを防ぐことが求められる。このような場合に、ISO白色度が前記範囲内である環式化合物を用いることにより、呈色不良が発生しにくく、高品質な化成品を得ることができる。 In addition, such cyclic compounds preferably have an ISO whiteness of 70% or more, more preferably 80% or more, measured according to the ISO whiteness test method specified in JIS P 8148:2001. Such cyclic compounds have few impurities and can be used as chemical products or raw materials for chemical products. In particular, when producing light-colored chemical products, it is necessary to prevent the color of the raw materials from transferring to the chemical product. In such cases, by using a cyclic compound with an ISO whiteness within the above range, color defects are less likely to occur and high-quality chemical products can be obtained.
なお、ISO白色度は、分光色彩白度計(例えば日本電色工業(株)製PF7000R)を用い、JIS P 8148:2001の「ISO白色度(拡散青色光反射率)の測定方法」に準拠して測定される。 The ISO whiteness is measured using a spectrophotometer (e.g., PF7000R manufactured by Nippon Denshoku Industries Co., Ltd.) in accordance with JIS P 8148:2001 "Method of measurement of ISO whiteness (diffuse blue light reflectance)".
ここで、式(1)で表される化合物についてさらに説明する。
飽和環、部分飽和環もしくは芳香環の5員環としては、例えば、フラン構造、チオフェン構造、ピロール構造、ピロリジン構造、テトラヒドロフラン構造、2,3-ジヒドロフラン構造、ピラゾール構造、イミダゾール構造、オキサゾール構造、イソオキサゾール構造、チアゾール構造、イソチアゾール構造等が挙げられる。
Here, the compound represented by formula (1) will be further explained.
Examples of the saturated ring, partially saturated ring, or aromatic 5-membered ring include a furan structure, a thiophene structure, a pyrrole structure, a pyrrolidine structure, a tetrahydrofuran structure, a 2,3-dihydrofuran structure, a pyrazole structure, an imidazole structure, an oxazole structure, an isoxazole structure, a thiazole structure, and an isothiazole structure.
飽和環の6員環としては、例えば、シクロヘキサン構造のような炭化水素系飽和環、ピペリジン構造、ピペラジン構造、トリアジナン構造、テトラジナン構造、ペンタジナン構造、キヌクリジン構造のような含窒素飽和環、テトラヒドロピラン構造、モルホリン構造のような含酸素飽和環、テトラヒドロチオピラン構造のような含硫黄飽和環等が挙げられる。 Examples of the six-membered saturated ring include hydrocarbon-based saturated rings such as a cyclohexane structure, nitrogen-containing saturated rings such as a piperidine structure, piperazine structure, triazinane structure, tetraazinane structure, pentazinane structure, and quinuclidine structure, oxygen-containing saturated rings such as a tetrahydropyran structure and a morpholine structure, and sulfur-containing saturated rings such as a tetrahydrothiopyran structure.
部分飽和環の6員環としては、シクロヘキセン構造、シクロヘキサジエン構造のような炭化水素系部分飽和環、ピペリジン構造のような含窒素部分飽和環、ピラン構造のような含酸素部分飽和環、チアジン構造のような含硫黄部分飽和環等が挙げられる。 Examples of the six-membered partially saturated ring include hydrocarbon partially saturated rings such as a cyclohexene structure or a cyclohexadiene structure, nitrogen-containing partially saturated rings such as a piperidine structure, oxygen-containing partially saturated rings such as a pyran structure, and sulfur-containing partially saturated rings such as a thiazine structure.
芳香環の6員環としては、ベンゼン構造のような炭化水素系芳香環、ピリジン構造、ピリダジン構造、ピリミジン構造、ピラジン構造、トリアジン構造、テトラジン構造、ペンタジン構造のような含窒素芳香環(含窒素不飽和環)等が挙げられる。 Examples of the six-membered aromatic ring include hydrocarbon aromatic rings such as a benzene structure, and nitrogen-containing aromatic rings (nitrogen-containing unsaturated rings) such as a pyridine structure, pyridazine structure, pyrimidine structure, pyrazine structure, triazine structure, tetrazine structure, and pentazine structure.
縮合環としては、例えば6員環と5員環との縮合環、2つの6員環の縮合環等が挙げられる。このうち、6員環と5員環との縮合環としては、例えば、インドール、インドレニン、インドリン、イソインドール、イソインドレニン、イソインドリン、イソドリジン、プリン、インドリジジンのようなインドール系構造が挙げられる。また、2つの6員環の縮合環としては、例えば、キノリン、イソキノリン、キノリジジン、キノキサリン、シンノリン、キナゾリン、フタラジン、ナフチリジン、プテリジンのようなキノリン系構造が挙げられる。 Examples of fused rings include a fused ring of a 6-membered ring and a 5-membered ring, and a fused ring of two 6-membered rings. Of these, examples of fused rings of a 6-membered ring and a 5-membered ring include indole-based structures such as indole, indolenine, indoline, isoindole, isoindolenine, isoindoline, isodolizine, purine, and indolizidine. Examples of fused rings of two 6-membered rings include quinoline-based structures such as quinoline, isoquinoline, quinolizidine, quinoxaline, cinnoline, quinazoline, phthalazine, naphthyridine, and pteridine.
Xは、単結合または1つ以上の炭素数を含む結合である。
Xが単結合である場合、環Aの環構成原子に対して酸素原子が直接結合している。
X is a single bond or a bond containing one or more carbon atoms.
When X is a single bond, the oxygen atom is directly bonded to a ring-constituting atom of ring A.
一方、1つ以上の炭素数を含む結合としては、例えば、炭素数1~4の炭化水素基、エーテル結合、エステル結合、アミド結合、カルボニル基、ビニリデン基等が挙げられ、これらのうちの1種または2種以上を組み合わせたものとされる。 On the other hand, examples of bonds containing one or more carbon atoms include hydrocarbon groups having 1 to 4 carbon atoms, ether bonds, ester bonds, amide bonds, carbonyl groups, vinylidene groups, etc., and these may be used alone or in combination of two or more.
このうち、炭素数1~4の炭化水素基は、直鎖または分枝鎖のいずれであってもよく、飽和または不飽和のいずれであってもよい。なお、炭化水素基の水素原子は、炭素数1~2のアルキル基、水酸基、アミノ基、カルボキシル基、ハロゲン原子等の置換基で置換されていてもよい。 Of these, the hydrocarbon group having 1 to 4 carbon atoms may be either linear or branched, and may be either saturated or unsaturated. The hydrogen atom of the hydrocarbon group may be substituted with a substituent such as an alkyl group having 1 to 2 carbon atoms, a hydroxyl group, an amino group, a carboxyl group, or a halogen atom.
なお、Xには、上述した結合に加え、任意の原子または原子団が含まれていてもよい。例えば、Xは、カルボニル基および1つ以上の炭素数を含む結合を含む原子団であってもよい。 In addition to the bonds described above, X may contain any atom or atomic group. For example, X may be an atomic group that contains a carbonyl group and a bond containing one or more carbon atoms.
Yは、水素原子またはアルキル基である。アルキル基の炭素数は好ましくは1~12とされ、より好ましくは1~4とされる。 Y is a hydrogen atom or an alkyl group. The number of carbon atoms in the alkyl group is preferably 1 to 12, and more preferably 1 to 4.
環Aが6員環である場合、R2~R6は、独立して、水素原子、水酸基、アミノ基、アルコキシ基、カルボキシル基またはカルボニル基である。また、環Aが5員環である場合、R2~R5は、独立して、水素原子、水酸基、アミノ基、アルコキシ基、カルボキシル基またはカルボニル基である。 When ring A is a 6-membered ring, R 2 to R 6 are independently a hydrogen atom, a hydroxyl group, an amino group, an alkoxy group, a carboxyl group, or a carbonyl group, and when ring A is a 5-membered ring, R 2 to R 5 are independently a hydrogen atom, a hydroxyl group, an amino group, an alkoxy group, a carboxyl group, or a carbonyl group.
なお、環Aが6員環である場合のR2~R6のいずれか、または、環Aが5員環である場合のR2~R5のいずれか、がカルボニル基である場合、環Aの環構成原子が炭素原子であり、かつ、その炭素原子と酸素原子との間が二重結合になっている構造を指して、カルボニル基という。 When ring A is a 6-membered ring and any of R 2 to R 6 is a carbonyl group, or when ring A is a 5-membered ring and any of R 2 to R 5 is a carbonyl group, the ring-constituting atom of ring A is a carbon atom and there is a double bond between the carbon atom and an oxygen atom, which is referred to as a carbonyl group.
環式化合物の具体例としては、例えば、安息香酸、フタル酸、イソフタル酸、テレフタル酸、ヘミメリット酸、トリメリット酸、トリメシン酸、メロファン酸、プレーニト酸、ピロメリット酸、フェニル酢酸、ヒドロキシフェニル酢酸、フェニル酪酸(フェニルラクテート)、ヒドロキシフェニル酪酸、フェニルピルビン酸、ヒドロキシフェニルピルビン酸、フェニル乳酸、ヒドロキシフェニル乳酸、アントラニル酸、ヒドロアトロパ酸、アトロパ酸、ヒドロケイ皮酸(クマル酸)、ケイ皮酸、サリチル酸(2-ヒドロキシ安息香酸)、m-サリチル酸(3-ヒドロキシ安息香酸)、p-サリチル酸(4-ヒドロキシ安息香酸)、メトキシ安息香酸、アミノ安息香酸、ヒドロキシ安息香酸、ピロカテク酸(2,3-ジヒドロキシ安息香酸)、β-レソルシル酸(2,4-ジヒドロキシ安息香酸)、ゲンチジン酸(2,5-ジヒドロキシ安息香酸)、γ-レソルシル酸(2,6-ジヒドロキシ安息香酸)、プロトカテク酸(3,4-ジヒドロキシ安息香酸)、α-レソルシル酸(3,5-ジヒドロキシ安息香酸)、トリヒドロキシ安息香酸、バニリン酸(4-ヒドロキシ-3-メトキシ安息香酸)、イソバニリン酸(3-ヒドロキシ-4-メトキシ安息香酸)、ベラトルム酸、没食子酸、シリング酸、アサロン酸、マンデル酸、バニルマンデル酸、アニス酸、ホモプロトカテク酸、ホモバニリン酸、ホモイソバニリン酸、ホモベラトルム酸、ホモフタル酸、ホモイソフタル酸、ホモテレフタル酸、フタロン酸、イソフタロン酸、テレフタロン酸、アトロラクチン酸、トロパ酸、メリロト酸、フロレト酸、ジヒドロカフェー酸、ヒドロフェルラ酸、ヒドロイソフェルラ酸、ウンベル酸、カフェー酸(コーヒー酸)、フェルラ酸、イソフェルラ酸、シナピン酸、シリンガ酸、デヒドロキナ酸、デヒドロシキミ酸、シキミ酸、コリスミ酸、L-トリプトファン、L-チロシン、プレフェン酸、アロゲン酸、L-フェニルアラニン等が挙げられる。 Specific examples of cyclic compounds include benzoic acid, phthalic acid, isophthalic acid, terephthalic acid, hemimellitic acid, trimellitic acid, trimesic acid, mellophanic acid, prenitic acid, pyromellitic acid, phenylacetic acid, hydroxyphenylacetic acid, phenylbutyric acid (phenyllactate), hydroxyphenylbutyric acid, phenylpyruvic acid, hydroxyphenylpyruvic acid, phenyllactic acid, hydroxyphenyllactic acid, anthranilic acid, hydroatropic acid, atropic acid, hydrophenyllactic acid, phenylacetate ... Cinnamic acid (coumaric acid), cinnamic acid, salicylic acid (2-hydroxybenzoic acid), m-salicylic acid (3-hydroxybenzoic acid), p-salicylic acid (4-hydroxybenzoic acid), methoxybenzoic acid, aminobenzoic acid, hydroxybenzoic acid, pyrocatechuic acid (2,3-dihydroxybenzoic acid), β-resorcylic acid (2,4-dihydroxybenzoic acid), gentisic acid (2,5-dihydroxybenzoic acid), γ-resorcylic acid (2,6-dihydroxybenzoic acid), protocatechuic acid (3,4-dihydroxybenzoic acid), α-resorcylic acid (3,5-dihydroxybenzoic acid), trihydroxybenzoic acid, vanillic acid (4-hydroxy-3-methoxybenzoic acid), isovanillic acid (3-hydroxy-4-methoxybenzoic acid), veratric acid, gallic acid, syringic acid, asaronic acid, mandelic acid, vanillylmandelic acid, anisic acid, homoprotocatechuic acid, homovanillic acid, homoisovanillic acid, homoveratric acid, homophthalic acid, homoisophthalic acid, homo These include terephthalic acid, phthalonic acid, isophthalonic acid, terephthalonic acid, atrolactic acid, tropic acid, mellitic acid, phloretic acid, dihydrocaffeic acid, hydroferulic acid, hydroisoferulic acid, umbellic acid, caffeic acid (caffeic acid), ferulic acid, isoferulic acid, sinapic acid, syringic acid, dehydroquinic acid, dehydroshikimic acid, shikimic acid, chorismic acid, L-tryptophan, L-tyrosine, prephenic acid, arogenic acid, and L-phenylalanine.
また、環式化合物の別の具体例としては、フラボノイド、リグナン、カルコン、スチルベノイド、アルカロイド、クルクミノイド、テルペノイド、サポニン、各種配糖体、各種ポリフェノール系芳香族化合物のようなポリフェノール類の他、アミノ酸、ビタミン等が挙げられる。 Other specific examples of cyclic compounds include polyphenols such as flavonoids, lignans, chalcones, stilbenoids, alkaloids, curcuminoids, terpenoids, saponins, various glycosides, and various polyphenol-based aromatic compounds, as well as amino acids and vitamins.
このうち、フラボノイドとしては、例えば、オーランチニジン、シアニジン、デルフィニジン、ヨーロピニジン、ルテオリニジン、ペラルゴニジン、マルビジン、ペオニジン、ペチュニジン、ロシニジンのようなアントシアニジン、プロシアニジンのようなアントシアニン、ナリンゲニン、エリオシトリン、ピノセムブリン、エリオジクチオールのようなフラバノン、カテキンのようなフラバン、アピゲニン、ルテオリン、バイカレイン、クリシンのようなフラボン、ケルセチン、ケンプフェロールのようなフラボノール、イソフラボン、イソフラバン、イソフラバンジオール、ゲニステインのようなイソフラボノイドの他、ネオフラボノイド、ビフラボノイド、オーロン、プレニル化フラボノイド、O-メチル化フラボノイド等が挙げられる。 Among these, examples of flavonoids include anthocyanidins such as aurantidin, cyanidin, delphinidin, europinidin, luteolinidin, pelargonidin, malvidin, peonidin, petunidin, and rosinidin, anthocyanins such as procyanidin, flavanones such as naringenin, eriocitrin, pinocembrin, and eriodictyol, flavans such as catechin, flavones such as apigenin, luteolin, baicalein, and chrysin, flavonols such as quercetin and kaempferol, isoflavones, isoflavones, isoflavanes, isoflavandiols, and isoflavonoids such as genistein, as well as neoflavonoids, biflavonoids, aurones, prenylated flavonoids, and O-methylated flavonoids.
また、リグナンとしては、例えば、ピノレシノール、ラリシレシノール、セコイソラリシレシノール、マタイレシノール、ヒドロキシマタイレシノール、シリンガレシノール、セサミン、アルクチゲニン、セサミノール、ポドフィロトキシン、ステガナシン等が挙げられる。 Examples of lignans include pinoresinol, lariciresinol, secoisolariciresinol, matairesinol, hydroxymatairesinol, syringaresinol, sesamin, arctigenin, sesaminol, podophyllotoxin, and steganacin.
さらに、スチルベノイドとしては、例えば、ピセアタンノール、ピノシルビン、プテロスチルベン、レスベラトロール、4’-メトキシレスベラトロール、ピノスチルベン、ピシアタノールのようなアグリコン、α-ビニフェリン、アンペロプシンA、アンペロプシンE、ジプトインドネシンC-カワン、ジプトインドネシンF-ダマールブア、ε-ビニフェリン、フレクスオソールA、グネチンH、ヘムスレヤノールD、ホペアフェノール、ジプトインドネシンB、バチカノールBのようなオリゴマー等が挙げられる。 Further examples of stilbenoids include aglycones such as piceatannol, pinosylvin, pterostilbene, resveratrol, 4'-methoxyresveratrol, pinostilbene, and piciatannol, and oligomers such as α-viniferin, ampelopsin A, ampelopsin E, diptoindonesin C-kawane, diptoindonesin F-dammarbua, ε-viniferin, flexosol A, gnetin H, hemsleyanol D, hopeaphenol, diptoindonesin B, and vaticanol B.
また、クルクミノイドとしては、例えば、クルクミン、ショウガオール等が挙げられる。 Curcuminoids include, for example, curcumin and shogaol.
さらに、テルペノイドとしては、例えば、ルテイン、ビタミンA、ビタミンE、βカロテンのようなカロテノイドの他、シトステロールのようなステロイド等が挙げられる。 Further examples of terpenoids include carotenoids such as lutein, vitamin A, vitamin E, and beta-carotene, as well as steroids such as sitosterol.
また、各種配糖体としては、例えば、サリシン、β-グルコガリン、サリチル酸グルコシド、サリドロシド、ガストロジン、ポプリン、フロリジン、アルブチンのようなフェノール配糖体、エスクリンのようなクマリン配糖体、ヘスペリジン、ルチンのようなフラボノイド配糖体、アストリンギン、ピセイド、ジプトインドネシンAのようなスチルベノイド配糖体等が挙げられる。 Examples of various glycosides include phenolic glycosides such as salicin, β-glucogallin, salicylic acid glucoside, salidroside, gastrodin, poplin, phloridzin, and arbutin, coumarin glycosides such as esculin, flavonoid glycosides such as hesperidin and rutin, and stilbenoid glycosides such as astringin, piceid, and diptoindonesin A.
さらに、各種ポリフェノール系芳香族化合物としては、例えば、チロソール、ヒドロキシチロソール、エスクレチン、フロレチン、ロスマリン酸、サルビアン酸A、レチクリン、パラクマリルアルコール、コニフェリルアルコール、カフェイルアルコール等が挙げられる。 Furthermore, various polyphenol-based aromatic compounds include, for example, tyrosol, hydroxytyrosol, esculetin, phloretin, rosmarinic acid, salvianic acid A, reticuline, paracoumaryl alcohol, coniferyl alcohol, caffeyl alcohol, etc.
また、アミノ酸としては、例えば、フェニルアラニン、チロシン等が挙げられる。
さらに、ビタミンとしては、例えば、ビタミンA、ビタミンD、ビタミンE等が挙げられる。
Furthermore, examples of amino acids include phenylalanine and tyrosine.
Furthermore, examples of vitamins include vitamin A, vitamin D, and vitamin E.
また、環式化合物のさらに別の具体例としては、芳香族化合物、脂環式化合物、脂肪族化合物、複素環式化合物等が挙げられる。 Further specific examples of cyclic compounds include aromatic compounds, alicyclic compounds, aliphatic compounds, and heterocyclic compounds.
このうち、芳香族化合物としては、例えば、バニリン、2-フェニルエタノール、フェニル酢酸、シンナミックアルコール、イソオイゲノール、フェルラ酸、4-アミノ安息香酸、アネトール、エストラゴール、アントラニル酸メチル、桂皮酸メチル、桂皮酸エチル、フェニルアセトアルデヒド、シンナミックアルデヒド、酢酸シンナミル、レゾルシン、4-ビニルフェノール、4-ビニル-2-メトキシフェノール、3,4-ジヒドロキシスチレン、ドーパミン、レボドパ、ハイドロキノン、クマリン、7-ヒドロキシクマリン、4-ヒドロキシクマリン、キシアメンマイシンA等が挙げられる。 Among these, examples of aromatic compounds include vanillin, 2-phenylethanol, phenylacetic acid, cinnamic alcohol, isoeugenol, ferulic acid, 4-aminobenzoic acid, anethole, estragole, methyl anthranilate, methyl cinnamate, ethyl cinnamate, phenylacetaldehyde, cinnamic aldehyde, cinnamyl acetate, resorcin, 4-vinylphenol, 4-vinyl-2-methoxyphenol, 3,4-dihydroxystyrene, dopamine, levodopa, hydroquinone, coumarin, 7-hydroxycoumarin, 4-hydroxycoumarin, and xiamenmycin A.
また、脂環式化合物としては、例えば、カルベオール、ペリラアルコール、ボルネオール、ジャスモン酸メチル、1,8-シネオール、L-メントン、バレンセン、ヌートカトン、α-ピネン、カンフェン、L-カルボン、ペリラアルデヒド、ミルテナール、酢酸L-メンチル、β-イオノン等が挙げられる。 Examples of alicyclic compounds include carveol, perilla alcohol, borneol, methyl jasmonate, 1,8-cineole, L-menthone, valencene, nootkatone, α-pinene, camphene, L-carvone, perilla aldehyde, myrtenal, L-menthyl acetate, and β-ionone.
さらに、脂肪族化合物としては、例えば、シス-3-ヘキセノール、酢酸シス-3-ヘキセニル、アセトイン、ネロール、ファルネソール、アルギニン、ムコン酸等が挙げられる。 Furthermore, examples of aliphatic compounds include cis-3-hexenol, cis-3-hexenyl acetate, acetoin, nerol, farnesol, arginine, muconic acid, etc.
また、複素環式化合物としては、例えば、ナイアシン、ナイアシンアミド、マルトール、インドール等が挙げられる。このうち、インドールとしては、例えば5,6-ジヒドロキシインドールが挙げられる。 Examples of heterocyclic compounds include niacin, niacinamide, maltol, and indole. Among these, an example of indole is 5,6-dihydroxyindole.
一方、環式化合物の誘導体としては、例えば、上述した化合物のエステル、酸無水物、アミド、酸ハロゲン化物、塩等、または、環式化合物から誘導される全ての化合物が挙げられる。 On the other hand, examples of derivatives of cyclic compounds include esters, acid anhydrides, amides, acid halides, salts, etc. of the above-mentioned compounds, or all compounds derived from cyclic compounds.
なお、環式化合物またはその誘導体の分子量は、特に限定されないが、120~1000であるのが好ましく、130~800であるのがより好ましい。 The molecular weight of the cyclic compound or its derivative is not particularly limited, but is preferably 120 to 1,000, and more preferably 130 to 800.
また、上記式(1)で表される環式化合物の環Aが、環構成原子が全て炭素原子である飽和環または部分飽和環の5員環である場合、R2~R5およびXが結合する環Aの炭素原子のうち、1つ以上が不斉炭素原子であるのが好ましい。また、上記式(1)で表される環式化合物の環Aが、環構成原子が全て炭素原子である飽和環または部分飽和環の6員環である場合、R2~R6およびXが結合する環Aの炭素原子のうち、1つ以上が不斉炭素原子であるのが好ましい。 When ring A of the cyclic compound represented by formula (1) is a five-membered saturated or partially saturated ring in which all of the ring-constituting atoms are carbon atoms, it is preferable that one or more of the carbon atoms of ring A to which R 2 to R 5 and X are bonded are asymmetric carbon atoms. When ring A of the cyclic compound represented by formula (1) is a six-membered saturated or partially saturated ring in which all of the ring-constituting atoms are carbon atoms, it is preferable that one or more of the carbon atoms of ring A to which R 2 to R 6 and X are bonded are asymmetric carbon atoms.
このような場合、環式化合物は立体異性体となる。この場合、本実施形態によれば、特定の立体異性体を高純度に含み、かつ、それ以外の立体異性体の含有率が低い環式化合物を高い収率で製造することが可能になる。その結果、不要な立体異性体の除去に伴う複雑な工程が必要なくなるので、製造コストの低コスト化を図ることができる。 In such a case, the cyclic compound becomes a stereoisomer. In this case, according to the present embodiment, it is possible to produce a cyclic compound with a high purity of a specific stereoisomer and a low content of other stereoisomers in a high yield. As a result, the complicated process of removing unnecessary stereoisomers is no longer necessary, and the production cost can be reduced.
また、上記式(1)で表される環式化合物においてXが結合する環Aの炭素原子をC1とし、R2が結合する環Aの炭素原子をC2とし、R3が結合する環Aの炭素原子をC3とし、R4が結合する環Aの炭素原子をC4とし、R5が結合する環Aの炭素原子をC5とし、R6が結合する環Aの炭素原子をC6としたとき、これらの炭素原子が不斉炭素原子である組み合わせが、下記(a)~(h)からなる群から選択される1種であることが好ましい。 In addition, in the cyclic compound represented by the above formula (1), when the carbon atom of ring A to which X is bonded is C1 , the carbon atom of ring A to which R2 is bonded is C2 , the carbon atom of ring A to which R3 is bonded is C3 , the carbon atom of ring A to which R4 is bonded is C4 , the carbon atom of ring A to which R5 is bonded is C5 , and the carbon atom of ring A to which R6 is bonded is C6 , it is preferable that the combination of these carbon atoms being asymmetric carbon atoms is one type selected from the group consisting of the following (a) to (h):
(a)C1
(b)C2
(c)C3
(d)C4
(e)C1およびC4
(f)C3およびC4
(g)C1、C3およびC4
(h)C3、C4およびC5
(a) C1
(b) C2
(c) C3
(d) C4
(e) C1 and C4
(f) C3 and C4
(g) C1 , C3 and C4
(h) C3 , C4 and C5
なお、下記式(2)は、上記式(1)で表される環式化合物に対し、上記C1~C6の表示を追記した式である。 The following formula (2) is a formula in which the above C 1 to C 6 indications are added to the cyclic compound represented by the above formula (1).
なお、環式化合物およびその誘導体は、上記式(2)で表される化合物であって、特に、3-デヒドロキネート、3-デヒドロシキミ酸、シキミ酸、コリスミ酸またはプレフェン酸であるのが好ましい。これらの化合物は、多くの分野で利用される化合物であって、その構造は以下の式で表される。 The cyclic compound and its derivatives are preferably compounds represented by the above formula (2), and more preferably 3-dehydroquinate, 3-dehydroshikimic acid, shikimic acid, chorismic acid, or prephenic acid. These compounds are used in many fields, and their structures are represented by the following formula:
・3-デヒドロキネート 3-dehydroquinate
・3-デヒドロシキミ酸 ・3-dehydroshikimic acid
・シキミ酸 ・Shikimic acid
・コリスミ酸 - Chorismic acid
・プレフェン酸 - Prephenic acid
以上のような環式化合物またはその誘導体の用途としては、特に限定されないが、例えば、香料組成物、化粧料組成物、医薬品、農薬、化学薬品、電気・電子部品用材料、合成繊維、樹脂、食品添加物等の各種化成品が挙げられる。また、環式化合物またはその誘導体は、各種化成品の原料としても用いられる。この原料としては、例えば、香料原料、化粧料原料、医薬品原料、農薬原料、化学薬品原料、電気・電子部品用原料、合成繊維原料、樹脂原料、食品添加物原料等が挙げられる。なお、原料とは、化成品の合成に用いられる中間体のことをいう。 The uses of the above-mentioned cyclic compounds or their derivatives are not particularly limited, but examples of such uses include various chemical products such as fragrance compositions, cosmetic compositions, pharmaceuticals, pesticides, chemicals, materials for electrical and electronic parts, synthetic fibers, resins, and food additives. Cyclic compounds or their derivatives are also used as raw materials for various chemical products. Examples of such raw materials include raw materials for fragrances, cosmetic materials, pharmaceutical materials, pesticide raw materials, chemical raw materials, raw materials for electrical and electronic parts, raw materials for synthetic fibers, raw materials for resins, and raw materials for food additives. Note that raw materials refer to intermediates used in the synthesis of chemical products.
以上、本発明の環式化合物またはその誘導体の製造方法を実施形態に基づいて説明したが、本発明はこれらに限定されるものではない。 The method for producing the cyclic compound or its derivative of the present invention has been described above based on the embodiments, but the present invention is not limited to these.
例えば、本発明の環式化合物またはその誘導体の製造方法は、前記実施形態に任意の工程が付加されたものであってもよい。 For example, the method for producing a cyclic compound or a derivative thereof of the present invention may include any step added to the above embodiment.
次に、本発明の具体的実施例について説明する。
1.環式化合物の製造
(実施例1)
[1]まず、バイオマスに前処理を施し、混合糖を得た。
Next, specific examples of the present invention will be described.
1. Preparation of cyclic compounds (Example 1)
[1] First, biomass was pretreated to obtain a sugar mixture.
[2]次に、増殖させた形質転換体を、混合糖と反応させ、培養液を得た。得られた培養液を遠心分離し、上清液(原料液体)を得た。 [2] Next, the grown transformant was reacted with a sugar mixture to obtain a culture solution. The culture solution was centrifuged to obtain a supernatant (raw liquid).
[3]次に、得られた原料液体の溶媒(水)を蒸発させ、濃縮液を得た。
[4]次に、濃縮液に活性炭を添加し、活性炭処理を施した。なお、活性炭は、濃縮液100gに対して0.4g使用した。
[3] Next, the solvent (water) of the obtained raw liquid was evaporated to obtain a concentrated liquid.
[4] Next, activated carbon was added to the concentrated liquid, and the concentrated liquid was subjected to activated carbon treatment. Note that 0.4 g of activated carbon was used per 100 g of the concentrated liquid.
[5]次に、塩酸を添加し、pHを8から3まで低下させることにより、溶質を析出させる晶析操作を行った。
[6]次に、析出した固体をろ過分離し、固体の析出物を回収した。
[5] Next, hydrochloric acid was added to lower the pH from 8 to 3, thereby carrying out a crystallization procedure to precipitate the solute.
[6] Next, the precipitated solid was separated by filtration, and the solid precipitate was collected.
[7]次に、得られた析出物を貧溶媒で洗浄した後、乾燥させ、固体の4-ヒドロキシ安息香酸(環式化合物)を得た。 [7] Next, the resulting precipitate was washed with a poor solvent and then dried to obtain solid 4-hydroxybenzoic acid (cyclic compound).
(実施例2~9)
製造条件を表1に示すように変更した以外は、実施例1と同様にして4-ヒドロキシ安息香酸(環式化合物)を得た。
(Examples 2 to 9)
Except for changing the production conditions as shown in Table 1, the same procedure as in Example 1 was carried out to obtain 4-hydroxybenzoic acid (cyclic compound).
(比較例)
[1]まず、バイオマスから微生物発酵によりメタンを製造した。
Comparative Example
[1] First, methane was produced from biomass through microbial fermentation.
[2]次に、メタンを原料とし、ゼオライトにモリブデンおよび鉄を担持した触媒による反応を経て、ベンゼンを製造した。その後、蒸留によりベンゼンを精製した。
[3]次に、ベンゼンから4-ヒドロキシ安息香酸を誘導した。
[2] Next, methane was used as a raw material and reacted with a catalyst made of zeolite carrying molybdenum and iron to produce benzene, which was then purified by distillation.
[3] Next, 4-hydroxybenzoic acid was derived from benzene.
(参考例)
市販されている4-ヒドロキシ安息香酸の試薬を用意した。
(Reference example)
A commercially available reagent of 4-hydroxybenzoic acid was prepared.
2.環式化合物の評価
2.1 純度の測定
各実施例および比較例で得られた環式化合物について、高速液体クロマトグラフィー(HPLC)により、4-ヒドロキシ安息香酸の純度を測定した。なお、純度は、回収した固体の全質量に対する4-ヒドロキシ安息香酸の質量の割合(単位:質量%)とした。
2. Evaluation of cyclic compounds 2.1 Purity measurement The purity of 4-hydroxybenzoic acid in the cyclic compounds obtained in each of the Examples and Comparative Examples was measured by high performance liquid chromatography (HPLC). The purity was defined as the ratio of the mass of 4-hydroxybenzoic acid to the total mass of the recovered solid (unit: mass%).
また、測定条件は、以下の通りである。
<4-ヒドロキシ安息香酸のHPLC分析条件>
カラム:COSMOSIL 5C18-AR-II(φ4.6mm×250mm)ナカライテスク社製
移動相:水/メタノール/過塩素酸=4/1/0.0075(vol/vol/vol)イソクラティック溶出
流量:1mL/mmin
カラム温度:40℃
検出方法:フォトダイオードアレイ(PDA)検出器(210nm)
測定結果を表1に示す。
The measurement conditions are as follows.
<HPLC analysis conditions for 4-hydroxybenzoic acid>
Column: COSMOSIL 5C18-AR-II (φ4.6 mm × 250 mm) manufactured by Nacalai Tesque Mobile phase: water/methanol/perchloric acid = 4/1/0.0075 (vol/vol/vol) isocratic elution Flow rate: 1 mL/mmin
Column temperature: 40°C
Detection method: Photodiode array (PDA) detector (210 nm)
The measurement results are shown in Table 1.
2.2 収率の評価
各実施例および比較例で得られた環式化合物について、高速液体クロマトグラフィー(HPLC)と質量測定により、4-ヒドロキシ安息香酸の収率を測定した。なお、収率は、原料液体中の4-ヒドロキシ安息香酸の量を高速液体クロマトグラフィー(HPLC)により算出し、回収した固体の質量と4-ヒドロキシ安息香酸の純度から回収量を算出し、原料液体中の4-ヒドロキシ安息香酸の量に対する回収した4-ヒドロキシ安息香酸の割合(単位:%)とした。
測定結果を表1に示す。
2.2 Yield Evaluation The yield of 4-hydroxybenzoic acid was measured for the cyclic compounds obtained in each of the Examples and Comparative Examples by high performance liquid chromatography (HPLC) and mass measurement. The yield was calculated by calculating the amount of 4-hydroxybenzoic acid in the raw liquid by high performance liquid chromatography (HPLC), calculating the recovered amount from the mass of the recovered solid and the purity of 4-hydroxybenzoic acid, and expressing it as the ratio (unit: %) of the recovered 4-hydroxybenzoic acid to the amount of 4-hydroxybenzoic acid in the raw liquid.
The measurement results are shown in Table 1.
2.3 白色度の評価
各実施例および比較例で得られた環式化合物ならびに参考例の市販試薬について、分光色彩白度計により、ISO白色度を測定した。
測定結果を表1に示す。
2.3 Evaluation of Whiteness The ISO whiteness of the cyclic compounds obtained in the Examples and Comparative Examples and the commercially available reagent of the Reference Example was measured using a spectrophotometer.
The measurement results are shown in Table 1.
2.4 処理能力の評価
各実施例および比較例における環式化合物の生産能力(単位時間当たりの固体の回収量)を相対的に評価した。具体的には、比較例における環式化合物の生産能力を1とし、各実施例における生産能力の相対値を算出した。
算出結果を表1に示す。
2.4 Evaluation of Processing Capacity The productivity of the cyclic compound (amount of solid recovered per unit time) in each Example and Comparative Example was relatively evaluated. Specifically, the productivity of the cyclic compound in the Comparative Example was set to 1, and the relative value of the productivity in each Example was calculated.
The calculation results are shown in Table 1.
表1から明らかなように、各実施例では、高い純度の環式化合物を高い収率で回収することができた。また、各実施例で回収した環式化合物は、白色度が比較的高いものであった。 As is clear from Table 1, in each example, a cyclic compound with high purity was recovered in high yield. In addition, the cyclic compounds recovered in each example had a relatively high degree of whiteness.
S01 原料液体調製工程
S02 濃縮工程
S03 活性炭処理工程
S04 晶析工程
S05 固液分離工程
S01 Raw liquid preparation step S02 Concentration step S03 Activated carbon treatment step S04 Crystallization step S05 Solid-liquid separation step
Claims (8)
濃縮された前記原料液体100gに対して活性炭を0.01~3g添加する活性炭処理を施す活性炭処理工程と、
前記活性炭処理が施された前記原料液体のpHを温度20~60℃の範囲で変化させる晶析処理を施し、前記原料液体の溶質を固体として析出させる晶析工程と、
前記原料液体から前記固体を粉末として回収する固液分離工程と、
を有することを特徴とする4-ヒドロキシ安息香酸またはその誘導体の製造方法。 a concentrating step of concentrating the raw material liquid containing 4-hydroxybenzoic acid or a derivative thereof by repeatedly contacting the raw material liquid with a heated heat transfer surface under a pressure of 80 kPa or less and heating the raw material liquid to 20 to 90° C. , thereby evaporating a solvent contained in the raw material liquid;
an activated carbon treatment step of adding 0.01 to 3 g of activated carbon to 100 g of the concentrated raw liquid;
a crystallization step in which the pH of the raw material liquid that has been treated with activated carbon is changed at a temperature in the range of 20 to 60° C. to cause the solute in the raw material liquid to precipitate as a solid;
a solid-liquid separation step of recovering the solid as a powder from the raw material liquid;
The present invention relates to a method for producing 4-hydroxybenzoic acid or a derivative thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019159035A JP7476498B2 (en) | 2019-08-30 | 2019-08-30 | Method for producing 4-hydroxybenzoic acid or its derivatives and method for producing chemical products |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019159035A JP7476498B2 (en) | 2019-08-30 | 2019-08-30 | Method for producing 4-hydroxybenzoic acid or its derivatives and method for producing chemical products |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021038156A JP2021038156A (en) | 2021-03-11 |
JP7476498B2 true JP7476498B2 (en) | 2024-05-01 |
Family
ID=74848177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019159035A Active JP7476498B2 (en) | 2019-08-30 | 2019-08-30 | Method for producing 4-hydroxybenzoic acid or its derivatives and method for producing chemical products |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7476498B2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002026374A1 (en) | 2000-09-28 | 2002-04-04 | Kansai Chemical Engineering Co., Ltd. | Heat transfer device |
WO2015156271A1 (en) | 2014-04-08 | 2015-10-15 | グリーンフェノール開発株式会社 | Coryneform bacterium transformant and method for producing 4-hydroxybenzoic acid or salt thereof used in same |
WO2019044773A1 (en) | 2017-08-30 | 2019-03-07 | 住友ベークライト株式会社 | Functional skin preparation for external use, antimicrobial agent and method for producing aromatic polyhydroxycarboxylic acid or derivative thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5212988A (en) * | 1975-07-18 | 1977-01-31 | Ajinomoto Co Inc | Purification of glutamic acid |
JP2744648B2 (en) * | 1989-06-29 | 1998-04-28 | 協和醗酵工業株式会社 | Method for producing amino acid granules |
-
2019
- 2019-08-30 JP JP2019159035A patent/JP7476498B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002026374A1 (en) | 2000-09-28 | 2002-04-04 | Kansai Chemical Engineering Co., Ltd. | Heat transfer device |
WO2015156271A1 (en) | 2014-04-08 | 2015-10-15 | グリーンフェノール開発株式会社 | Coryneform bacterium transformant and method for producing 4-hydroxybenzoic acid or salt thereof used in same |
WO2019044773A1 (en) | 2017-08-30 | 2019-03-07 | 住友ベークライト株式会社 | Functional skin preparation for external use, antimicrobial agent and method for producing aromatic polyhydroxycarboxylic acid or derivative thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2021038156A (en) | 2021-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Setyaningsih et al. | Stability of 40 phenolic compounds during ultrasound-assisted extractions (UAE) | |
Collet et al. | Optically active (C3)-cyclotriveratrylene-d9. Energy barrier for the" crown to crown" conformational interconversion of its nine-membered ring system | |
Wang et al. | Synthesis and self-assembly of 1-deoxyglucose derivatives as low molecular weight organogelators | |
HUE032843T2 (en) | Conversion of carbohydrates to hydroxymethylfurfural (HMF) and derivatives | |
CN113677783A (en) | Water soluble additive composition | |
JP7476499B2 (en) | Method for producing shikimic acid or its derivatives | |
JP7476498B2 (en) | Method for producing 4-hydroxybenzoic acid or its derivatives and method for producing chemical products | |
JP2020122155A (en) | Method for removing geniposide or genipin or both | |
Percevault et al. | Extraction of plant and algal polyphenols using eutectic solvents | |
JP5295744B2 (en) | Method for producing theacinensin | |
JP6052183B2 (en) | Gel of reduced pyrroloquinoline quinone | |
JP5255862B2 (en) | Antidiabetic | |
Lue et al. | Scalable preparation of high purity rutin fatty acid esters | |
JP2021038158A (en) | Production method of cyclic compound or derivative thereof | |
SU1836326A3 (en) | Method for separating lactic acid from aqueous medium containing this acid | |
JP5602936B2 (en) | Spray-dried crystalline active ingredient | |
CN104099023B (en) | Pimaric acid type resin acid product and method for extracting pimaric acid type resin acid product from torreya grandis aril | |
WO2021193565A1 (en) | Production method for cyclic compound or derivative thereof | |
WO2021157413A1 (en) | Cosmetic, and method for producing cyclic compound or derivative thereof | |
FR2694020A1 (en) | Process for the preparation of aromatic substances enzymatically | |
Wang et al. | Tetrabutylammonium bromide-based hydrophobic deep eutectic solvent for the extraction and separation of dihydromyricetin from vine tea and its inhibitory efficiency against xanthine oxidase | |
JP2006508654A (en) | Enzymatic production of acylflavonoid derivatives. | |
JP2010235574A (en) | Fucoxanthin clathrate | |
Wen et al. | One-step extraction and hydrolysis of crocin into crocetin by recyclable deep eutectic solvents | |
EP2221300B1 (en) | Methods for resolution of the mixture of the optical isomers, especially the racemate of pinocembrin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220704 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230710 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230725 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230922 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240118 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240319 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240401 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7476498 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |